Measurement and Assessment of Work of Breathing in Neonates During Nasal Continuous Positive Airway Pressure Therapy by Lomp, Andrea & Lomp, Andrea
1 
 
 
 
 
 
 
Measurement and Assessment of 
Work of Breathing in Neonates  
During Nasal Continuous Positive Airway Pressure 
Therapy 
 
 
Andrea Lomp 
Fachärztin der Kinder- und Jugendmedizin  
(Specialist in Paediatrics) 
 
Department of Paediatrics  
Imperial College London 
 
 
 
 
Thesis submitted for the degree of MDres 
2010 
2 
 
 
 
 
 
 
 
 
 
 
 
I hereby certify that the thesis I am presenting for examination for the 
MDres degree is solely my own work other than where I have clearly 
indicated that it is the work of others. I consider the work to be a 
complete thesis fit for examination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my godson  
Alex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
Abstract 
 
Introduction Nasal continuous positive airway pressure (nCPAP) is a 
widely used form of non-invasive respiratory support in neonates. The 
general aim of nCPAP therapy is to improve lung volume, oxygenation 
and decrease work of breathing. There is little data to guide clinicians 
on how to adjust the pressure and what parameter nCPAP should be 
titrated against. This is due to the lack of commercially available 
equipment to measure lung mechanics in patients receiving non-
invasive respiratory support. In mechanically ventilated patients, 
measurements of work of breathing have been found to be useful in 
optimising ventilation strategies. An indicator of work of breathing or 
estimate of the metabolic and oxygen cost of breathing is the pressure 
time product (PTP) Objectives: To develop a monitoring system for the 
measurement of work of breathing in neonates on nCPAP, to 
investigate the effects of different nCPAP levels on PTP and to identify 
non-invasively determined predictors of PTP. Methods PTP’s (PTPoe= 
oesophageal, PTPga=gastric and PTPdi=diaphragmatic pressure time 
product) derived by oesophageal gastric pressure transducer was 
compared with parameters derived by respiratory inductance 
plethysmography. Subjects were randomised to receive nCPAP level 
sequences of 2, 4, 6 and 8 cmH2O. Main results 37 of 57 subjects 
were analysed. Median gestational age 30 ± 4.9 weeks, median birth 
weight 1234 ± 443 g, chronological age ≤ 24 hours 24 subjects (64.9%) 
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and baseline FiO2 ≤ 0.35. PTP’s decreased with increasing nCPAP level 
(p < 0.05). “Optimal” nCPAP as determined by the lowest PTPoe and 
PTPdi occurred between 6-8 cmH2O for 56 % of the subjects. “Optimal” 
nCPAP as defined by the lowest PTPga occurred between 6-8 cmH2O 
for 39% of the subjects. Respiratory rate, abdominal excursion 
decreased, Te increased and heart rate remained unchanged with 
increased nCPAP level. PTPoe correlated best out of all three PTP’s 
with selected variables derived by non-invasive techniques. Respiratory 
rate explained 36.7% of the variance of PTPoe and abdominal 
excursion explained 45.5% of the variance of PTPoe. Best fitted 
prediction model for PTPoe included respiratory rate, phase angle, 
abdominal excursion, birth weight, gestational age and applied nCPAP 
level and explained 65.8% of the variance of PTPoe. One suspected 
pneumothorax was reported (1.7%). Conclusion: Respiratory muscle 
work load is affected by changes in nCPAP levels and can be predicted 
more accurately by a model consisting of respiratory rate, phase angle, 
abdominal excursion, gestational age and birth weight than by clinical 
parameters alone. 
 
 
 
 
 
 
6 
 
Acknowledgments 
 
There have been many people who have been involved with this 
project, without whom, I would not have been able to carry out any of 
this work. 
A special thank you to the Save the Baby Charitable Trust and Sydney 
and Phyllis Goldberg Trust for their financial support and Dr Simon 
Bignall,  Dr Paul Dixon (Viasys Healthcare Inc.), Mr Tom Leenhoven 
(Viasys Healthcare Inc.), Mr Ted Tabor (Philips-Respironics) and Mr 
Koot Kotzé (TF Design Ltd.) for their technical support.  
I am very grateful for all my friends and colleagues at Imperial for their 
advice and continuous encouragement throughout my project. 
I am very grateful to all staff at the Tygerberg Hospital, Cape Town for 
welcoming and supporting me and making a very difficult part of my 
study enjoyable. I would like to thank Prof Johan Smith, Dr Helena 
Rabie, Dr Adri Becker, Mr Johan Botha, Dr Beate Kampman and Dr 
Robert Boyle. Without their support I would not have been able to 
complete my study successfully.   
In particular I would like to thank all parents and patients for 
participating in my study and for their trust and believe in this research.  
Finally, special thanks to my supervisor Dr Parviz Habibi, for believing 
in me and giving me the opportunity to obtain a higher degree.  
 
 
7 
 
Table of contents 
 
List of figures        11 
List of tables        14 
List of abbreviations       16 
1. Introduction        18 
1.1. Respiratory distress      18 
1.2. Respiratory system       20 
1.2.1. Respiratory apparatus     20 
1.2.2. Mechanism of breathing     23 
1.3. Respiratory muscle fatigue/ failure    28 
1.4. Nasal continuous positive airway pressure   30 
1.4.1. Infant Flow       31 
1.4.2. Effects on lung mechanics     33 
1.4.2.1. Effects on work of breathing   34 
1.4.2.2. Effects on breathing pattern as derived by  
       respiratory inductance plethysmography    35 
1.4.2.3. Effects on other clinical parameters  37 
1.4.2.4. Effects of the infant flow system on  
lung mechanics     38 
1.5. “Optimal” CPAP       39 
1.6. Adverse effects       43 
1.7. Outcome of nCPAP treatment     44 
1.8. Current practice       45 
8 
 
1.9. Work of breathing       45 
1.9.1. Work of breathing in clinical practise   48 
1.10. Equipment       52 
1.10.1. Oesophageal Gastric Manometry   52 
1.10.2. Respiratory inductance plethysmography  55 
1.11. Study rational      57 
2.  Methods and Materials      59 
2.1. Hypotheses        59 
2.2. Aim and objectives       60 
2.3. Project overview       61 
2.4. Ethics and Funding       62 
2.5. Description of population and environment   63 
2.6. Study eligibility criteria      65 
2.7. Interventions       66 
2.8. Equipment         66 
2.8.1. Equipment set up      67 
2.8.2. Oesophageal gastric pressure transducer   67 
2.8.3. Respiratory inductance plethysmography  68 
2.8.4. Respiratory Monitor      69 
2.8.5. Infant Flow System       70 
2.8.6. Software for data collection     71 
2.8.7. Software for data analysis     73 
2.8.8. Safety and infection control    77 
9 
 
2.8.9. Validation of equipment     78 
2.8.9.1. Validation of pressure measurements   78 
2.8.9.2. Validation of Respitrace band   81 
2.9. Procedures        83 
2.10. Preliminary  studies      85 
2.11. Sample size       87 
2.12. Randomisation sequence generation   87 
2.13. Blinding       88 
2.14. Reproducibility of data     88 
2.15. Statistical methods      89 
3. Results         92 
3.1. Participant flow       92 
3.2. Baseline data       93 
3.3. Effect of randomisation code on PTP    94 
3.4. Effect of  adjustment period on PTP    94 
3.5. Reproducibility of “optimal” CPAP    95 
3.6. Nominal versus received nCPAP level    97 
3.7. Relationship between selected variables and nCPAP  98 
3.8. Relationship between PTP values and listed variables 101 
3.9. Distribution of “optimal” CPAP levels    103 
3.10. Percentage change of PTP between nCPAP levels 105 
3.11. Predictors of PTP      105 
10 
 
3.12. Relationship between PTP and demographic / clinical   
characteristics       112 
3.13. Adverse events      113 
4. Discussion        114 
4.1. Relationship between selected variables and nCPAP levels 114 
4.2. Relationship between PTP values and variables   117 
4.3. “Optimal” CPAP       118 
4.4. Predictors of pressure time products    119 
4.5. Subgroup analysis       122 
4.6. Limitations of the study      123 
4.7. Summary         132 
4.8. Conclusion        134 
4.9. Future work        135 
5. References        136 
6. Appendices        154 
 
 
 
 
 
 
 
 
 
11 
 
List of figures 
 
Figure 1 Respiratory apparatus     20 
Figure 2 Infant Flow Generator (photo)    31 
Figure 3 Infant Flow Generator (image)    32 
Figure 4 Fluidic flip       33 
Figure 5 Illustration of the placement of an oesophageal gastric 
catheter        53 
Figure 6 Illustration of the calculation of oesophageal and  54 
gastric pressure time product 
Figure 7 Illustration of thoraco abdominal asynchrony  
in infants       55 
Figure 8 Phase shift between ribcage and abdominal waves 56 
Figure 9 Illustration of different steps throughout the project 61 
Figure 10 Equipment set up on the neonatal high care unit 67 
Figure 11 Diagram of equipment set up    68 
Figure 12 Oesophageal gastric pressure transducer  69 
Figure 13 Respitrace bands and oesophageal gastric pressure 
transducer in situ      70 
Figure 14 Data acquisition unit     70 
Figure 15 CO2SMO plus respiratory monitor    71 
Figure 16 Flow sensor       71 
Figure 17 Custom made Infant Flow Driver    72 
Figure 18 Data collection screen     74 
12 
 
Figure 19 Data analysis screen     76 
Figure 20 Equipment set up for validation of pressure 
measurements      78 
Figure 21 Correlation of pressure measurements of 
 hand pump and water manometer   79 
Figure 22 Adjustable wooden block     81 
Figure 23 Respitrace band output at different lengths  82 
Figure 24 Participant flow chart     92 
Figure 25 Reproducibility of PTPoe     95 
Figure 26 Reproducibility of PTPdi     96 
Figure 27 Reproducibility of PTPga     97 
Figure 28 Nominal (set) vs. mean received (measured)  
nCPAP       97 
Figure 29 Distribution of nCPAP levels with lowest  
oesophageal pressure time product (PTPoe)  103 
Figure 30 Best fitted model vs. PTPoe    107 
Figure 31 Fitted model abdominal excursion + CPAP 
vs. PTPoe       107 
Figure 32  Fitted model phase angle + CPAP vs. PTPoe  108  
Figure 33 Fitted model respiratory rate + CPAP vs. PTPoe 108 
Figure 34 Fitted model vs. PTPdi     110 
Figure 35 Fitted model vs. PTPga     111 
Figure 36 PTPga at different chronological ages   112 
13 
 
Figure 37a  Frequency distribution of PTPdi at nominal  
CPAP levels       153 
Figure 37b Frequency distribution of PTPga at nominal  
  CPAP levels       154 
Figure 37c Frequency distribution of PTPoe at nominal  
  CPAP levels       155 
Figure 38a-c Linear relationship of PTPoe at nominal  
CPAP levels for each subject    158 
Figure 39 The effect of different adjustment periods on  
  PTPoe at different CPAP levels    160 
Figure 40a Change of diaphragmatic pressure time product 
  at recCPAP (=measured CPAP)    161 
Figure 40b Changes of gastric pressure time product at  
recCPAP (=measured CPAP)    162 
Figure 40c Changes of oesophageal pressure time product at 
  recCPAP (=measured CPAP)    163 
Figure 41  Main running screen     168 
 
 
 
 
 
 
14 
 
List of tables 
 
Table 1 Summary of effects of the Infant Flow System  38 
Table 2 “Optimal” CPAP      42 
Table 3 Studies investigating the clinical application of work of 
   breathing       51 
Table 4 Performance of catheters at beginning and  
end of project      80 
Table 5 Demographic data      93 
Table 6 Clinical characteristics     93 
Table 7 Nominal (set) vs. received (measured) CPAP  97 
Table 8 Trends of selected variables at CPAP   97 
Table 9 Changes of selected variables at nominal nCPAP 100 
Table 10 Correlation coefficient of various variables with  
PTPoe at nominal CPAP levels    101 
Table 11 Correlation coefficient of various variables with  
  PTPdi at nominal CPAP levels    102 
Table 12 Correlation coefficient of various variables with 
  PTPga at nominal CPAP levels    102 
Table 13 Number of subjects at “optimal” CPAP   104 
Table 14 Percentage change in PTP at different CPAP levels  105 
Table 15 Best fitted model for PTPoe     106 
Table 16 Best fitted model for PTPdi     109 
15 
 
Table 17 Best fitted model for PTPga    111 
Table 18 Linear mixed effects model analysis of the effect 
of the randomisation order on PTPoe   159 
Table 19 Relationship between PTPoe and the clinical 
characteristics of the sample population   169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
16 
 
List of Abbreviations 
 
 
AB   abdomen 
CA   chronological age 
CPAP   continuous positive airway pressure 
CXR   chest x ray 
EELV   end expiratory lung volume 
FiO2   fraction of inspired oxygen 
FRC   functional residual capacity 
GA   gestational age 
HIVe   human immunodeficiency virus exposed 
HR   heart rate 
iWOB   inspiratory work of breathing 
nCPAP  nasal continuous positive airway pressure 
PA   phase angle 
Pao   airway opening pressure 
PDA   persistent ductus arteriosus 
Poe   oesophageal pressure  
PSV   pressure support ventilation 
PTPdi   diaphragmatic pressure time product 
PTPga  gastric pressure time product 
PTPoe  oesophageal pressure time product 
PTV   patient triggered ventilation 
RC   ribcage 
17 
 
RDS   respiratory distress syndrome 
RecCPAP  received CPAP 
recCPAP  received CPAP 
REM    rapid eye movement 
RIP   respiratory inductance plethysmography 
RWOB  resistive work of breathing 
SE   standard error 
SD   standard deviation 
SIMV   synchronised intermittent ventilation 
SpO2   peripheral oxygen saturation 
TAA   thoraco abdominal asynchrony 
Te   expiratory time 
RR   respiratory time 
VDRL   venereal research laboratory 
Vt   tidal volume 
WOB   work of breathing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
1. Introduction 
 
1.1 Respiratory distress  
Respiratory diseases are the leading cause of morbidity in the neonate 
in both developing and developed countries. Over the last few years 
several treatment modalities have been introduced aimed at reducing 
the incidence and severity of respiratory distress. Among these are the 
induction of lung maturation with antenatal steroids, the administration 
of surfactant to treat immature lungs, improved strategies for 
mechanical ventilation and the use of non-invasive respiratory support 
including nasal continuous positive airway pressure (nCPAP) (1).  
  
The definition of respiratory distress is based on five signs and 
symptoms (tachypnea > 60/min, central cyanosis in room air, nasal 
flaring, retractions and expiratory grunting). Causes of respiratory 
distress are commonly of cardiac, respiratory, neurological, 
haematological or miscellaneous origin (1). 
 
The neonatal respiratory system differs from the adult respiratory 
system both in anatomy and physiology.  These include differences in 
the response to chemoreceptor stimuli, respiratory reflexes, 
configuration of the chest wall and its interaction with the respiratory 
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muscles and mechanisms to maintain functional residual capacity 
(FRC) (2).  
The following chapters will describe the neonatal respiratory system 
and its vulnerability and unique coping strategies in relation to 
respiratory muscle fatigue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
1.2 Respiratory system 
1.2.1 Respiratory apparatus 
The respiratory system consists of airways, lungs and respiratory 
muscles (Fig.1). 
 
 
 
 
 
 
 
 
 
 
Fig.1: Respiratory apparatus (Textbook of Neonatology, Janet M. 
Rennie, N.R.C. Roberton) 
 
The nasal portion of the airways is supported by its bony and 
cartilaginous portions. Nasal resistance to airflow is determined by the 
physical dimension of the individual and comprises one third of the total 
pulmonary resistance (3).  The prime function of the nose is to act as an 
entry port for respiration, humidifying and warming of the inspired gas 
and trapping of foreign particles. Infants are mostly nose breathers but 
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full term infants can establish oral breathing in the presence of nasal 
obstruction (4).  
 
The pharyngeal portion of the airway is very compliant. This can lead to 
collapse and obstruction of the airway, in the absence of active muscle 
contraction, with neck flexion or from negative pressure during 
inspiration. Changes in laryngeal diameter modulate airway resistance 
and lung volume can be maintained by expiratory adduction of the vocal 
cords (5). 
 
Although the trachea and main bronchi are supported by cartilaginous 
rings, smooth muscle contractions can cause narrowing and an 
increase in resistance. In the newborn the small airways are more 
compliant and expiratory collapse tends to lead to air trapping.  
 
The chest wall in neonates is very compliant. The ribs are mainly 
composed of cartilage and extend horizontally from the vertebral 
column (6). In adults the volume of the ribcage can be increased by 
elevating the ribs. In infants the ribs are already elevated and can not 
contribute further to an increase in tidal volume (7). Chest wall muscle 
contraction can stabilise the rib cage, minimising inward displacement 
of the rib cage by diaphragmatic contraction during inspiration.  
22 
 
During rapid eye movement (REM) sleep which is 60% of the total sleep 
time in the newborn (8); the intercostal muscles are inhibited resulting in 
a paradoxical inward motion of the rib cage by diaphragmatic 
contractions during inspiration (9).  This is associated with a reduced 
functional residual capacity (FRC) (10) and an increase in 
diaphragmatic work load (11) resulting in inefficient ventilation with high 
energy consumption which may contribute to diaphragmatic fatigue and 
respiratory failure (12).  
 
The main inspiratory muscle is the diaphragm, a dome shaped muscle 
attached to the ribs. Diaphragmatic contraction results in the abdominal 
contents moving downward, increasing the vertical dimension of the 
thoracic cavity. If the diaphragm’s decent is impeded by the abdominal 
pressure, then the lower ribs are pulled up and increase the rib cage 
diameter (13).  The configuration of the adult and neonatal diaphragm 
differs. The latter being relatively flat with a wide angle of insertion on 
the rib cage, resulting in the absence of the area of apposition (9), 
which makes the diaphragm less efficient. 
 
Muscle fibres can be divided into two categories by histochemical and 
functional characteristics. Type I fibres are oxidative with a slow twitch 
and fatigue resistant, type IIa and IIc fibres are oxidative, glycolytic with 
a fast twitch and fatigue resistant, whereas type IIb fibres are glycolytic 
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with a fast twitch and fatigue rapidly. The proportion of type I fibres is 
low in neonates, which makes them more prone to respiratory muscle 
fatigue (14). 
 
 
1.2.2 Mechanisms of breathing 
The main complex of the respiratory control system is based in the 
brainstem. The overall purpose is to maintain blood gas homeostasis. 
Respiratory neurones receive information via the afferent limb from 
forebrain, hypothalamus, central and peripheral chemoreceptors, 
muscles, joints and pain receptors. The efferent limb transmits the 
central signals to the end organs to increase or decrease respiratory 
output (15). 
 
Neonates respond to various stimuli in different ways to adults for 
example; at low oxygen levels the neonate often decreases ventilation, 
whereas adults increase respiratory effort. The mechanisms involved 
are not well understood but postnatal maturational changes in 
mechanical properties of the lung and airways, chemoreceptors, 
neuromuscular junctions and central neurons have been proposed (13). 
 
The pattern of breathing in the neonatal period is characterised by 
respiratory reflexes, which arise from stretch receptors in the airways, 
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the chest wall or upper airways. Those reflexes include the Hering-
Breuer inflation reflex, Hering-Breuer expiratory reflex, Heads 
paradoxical reflex and the intercostal phrenic inhibitory reflex (2).  
 
The Hering-Breuer inflation reflex originates from stretch receptors 
within the airways and has an afferent path within the nervus vagi (16). 
It is documented that inflation of the lung causes cessation of 
inspiration, producing a rapid and shallow tidal breathing within the tidal 
volume range. Several methods have been used to provoke the reflex; 
amongst these are lung inflation by application of CPAP and 
mechanical ventilation. The strength of the reflex in relation to 
gestational age (17-19) and sleep state  is debated, but it was 
demonstrated that the strength of the reflex is increased in patients with 
non-compliant lungs  and by the administration of theophyllin.  
 
The Hering-Breuer expiratory reflex causes expiratory muscle 
contraction at prolonged inhalation. Active expiration seen in ventilated 
neonates at slow rate and over long inflation times may be a 
manifestation of this reflex (20). 
 
The Hering-Breuer deflation reflex causes a prolonged inspiration on 
rapid deflation of the lung caused by a pneumothorax or by vigorous 
expiratory effort which takes the lung below its end-expiratory level (21). 
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The Head’s paradoxical reflex (22) produces a stronger contraction of 
the diaphragm and augmented breath by rapid inflation of the lung. In 
the perinatal period its function is to obtain sufficient lung expansion to 
establish an FRC and to increase lung compliance by inflating the lung 
and re-open partially collapsed lung fields. This response is also seen in 
intermittent positive pressure ventilation (23). 
 
The intercostal phrenic inhibitory reflex is provoked by rapid distortion of 
the chest wall and can result in a decrease in inspiration usually during 
REM sleep (24). It is inhibited by an increase in FRC resulting from the 
application of respiratory support including CPAP. CPAP may also 
eliminate the reflex by improving chest wall stability (25).  
 
Breathing patterns in infants are often characterised by periodic 
breathing, an alternation of breathing periods and apnoea. It is common 
particularly in preterm infants and considered to be a non pathological 
condition of the immature infant (26).  
 
Furthermore, breathing might be interrupted by apnoeic episodes. 
Apnoea is a pause of breathing of longer than 10 to 15 seconds, often 
associated with bradycardia, cyanosis or both (27). The most common 
cause of apnoea is prematurity. Other possible causes include infection, 
seizures, intracranial haemorrhage, gastro oesophageal reflux and 
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drugs (28). There are different types of apnoea including: central, 
obstructive or mixed.  
Central apnoeas are a pause in alveolar ventilation due to a lack of 
diaphragmatic activity, which is due to immaturity of brainstem control of 
central respiratory drive with poor signal transmission to the respiratory 
muscles.  
Obstructive apnoeas are characterised by a pause in alveolar 
ventilation due to a lack of airflow within the upper airway, particularly at 
the level of the pharynx. The pharynx collapses from negative pressure 
generated during inspiration, because the muscles responsible to keep 
the airway open are too week in the preterm infant. Once collapsed, 
mucosal adhesive forces tend to prevent the reopening of the airway 
during expiration. Neck flexion will worsen this form of apnoea. 
Excessive secretions in the nasopharynx may also cause obstructive 
apnoea.  
Mixed apnoeas are a combination of the two.  
The management of apnoea of prematurity involves either 
pharmacological therapy for central apnoeas or administration of 
respiratory support including nCPAP for obstructive and mixed apnoeas 
(28). 
 
The chest wall composition affects the FRC of the neonate, which is 
defined as the balance between outward recoil of the chest wall and 
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inward elastic recoil of the lung. The FRC is decreased due to a 
decreased outward recoil of the chest wall (9) leading to atelectasis and 
poor gas exchange.  
 
The neonate has developed strategies to keep the end expiratory lung 
volume (EELV) above FRC to prevent lung collapse by interrupting 
expiratory flow.  
These include;  
1. retarding the expiratory flow by early inspiratory muscle activity 
(“diaphragmatic breaking” or “post-inspiratory activity of the 
diaphragm”) before the end of expiration increased resistance to 
expiration by the upper airway through laryngeal muscle activity 
(29-32). 
2. increased resistance to expiration by the upper airway through 
laryngeal muscle activity (33). 
3. increase in respiratory rate (34). 
 
 It is thought that CPAP eliminates these energy consuming 
mechanisms of dynamic elevation of FRC (35) by mechanical splinting 
of the upper airway (36) and an increase in lung volume (35;37). 
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1.3 Respiratory muscle fatigue / failure 
Respiratory muscle fatigue occurs when the ability of the muscle to 
generate force is impaired by inadequate energy supply relative to 
demand (38;39). This results in biomedical changes including depletion 
of glycogen stores and decrease in pH which impairs calcium release 
(40). An increase in energy demand occurs on the respiratory muscle 
when an increased load such as lung disease or respiratory muscle 
weakness of any origin is added.  
 
Causes of respiratory muscle fatigue include lung, or chest wall 
disease, neuromuscular disease, poor nutrition, insufficient blood flow 
or hypoxia (40). Another mechanism leading to muscle fatigue is 
hyperinflation of the lungs, that can impair the length-tension 
relationship of the diaphragm and therefore reducing the endurance 
time  (41;42) and the capacity to generate force (43;44). This results in 
distortion of the highly compliant chest wall by diaphragmatic 
contractions, which is very energy consuming (11;45). 
Acute fatigue is reversible upon rest whereas in chronic fatigue the 
force and endurance of the respiratory muscles are considerably 
reduced and do not fully recover upon rest (40). 
 
In neonates coping strategies for increased respiratory muscle work 
load are impaired because of the immaturity of the respiratory pump 
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(46)  and high energy consumption during breathing, which makes them 
more susceptible to respiratory muscle fatigue (47). If coping 
mechanisms fail respiratory failure occurs, which is a common clinical 
phenomenon in premature infants (48).  
 
Clinical manifestations of respiratory fatigue included an increase in 
respiratory rate, paradoxical breathing, increased carbon dioxide (CO2) 
tension levels and a decrease in pH (49), therefore resulting in 
hypoventilation, CO2 retention and hypoxia. Respiratory failure is 
conventionally defined as an arterial oxygen tension ≤ 60 mmHg, and or 
arterial carbon dioxide tension ≥ 45 mmHg (38).  
 
The first line of management in acute respiratory failure includes 
supplementary oxygen then progressing to non-invasive respiratory 
support such as nasal continuous positive airway pressure (nCPAP) 
and finally mechanical ventilation. 
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1.4 Nasal continuous positive airway pressure  
Nasal continuous positive airway pressure (nCPAP) is the non-invasive 
application of positive pressure to the airways of the spontaneously 
breathing patient via nasal prongs, nasopharyngeal prongs or nasal or 
face-mask. It is a very common and widely used technique for treatment 
of respiratory failure in neonates.  
It was firstly described by Gregory et al. in 1971 in infants with 
respiratory distress syndrome (50). Originally, CPAP was administered 
via boxes (50), endotracheal tubes (51), face chambers (52) and face 
masks (53). Those devices were associated with complications 
including poor access to the patient and accumulation of CO2. Since 
then new devices were designed with various different nasal interfaces 
(54-56).  
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1.4.1 Infant Flow System 
The Infant Flow System (Viasys Healthcare Inc.) is now one of the most 
commonly used methods to deliver nCPAP. It has a unique design, 
which provides respiratory support working in harmony with the infant’s 
own breathing efforts, by using Venturi and Fluidic Flip technology.  
 
.  
 
 
 
 
Fig. 2: Infant Flow Generator (photo Viasys Healthcare) 
 
Venturi effect: 
The Venturi effect is the reduction in fluid pressure that results when a 
fluid flows through a constricted section of pipe. According to the laws, 
governing fluid dynamics, a fluid's velocity must increase as it passes 
through a constriction to satisfy the conservation of mass, while its 
pressure must decrease to satisfy the conservation of energy. The flow 
provided by the Infant Flow Generator (Fig.2) is passing through narrow 
twin injector nozzles (Fig.3), leading to an acceleration of flow and a 
reduction in its pressure. These mechanisms facilitate inspiration.  
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Twin injector nozzles      
 
 
 
Fig.3: Infant Flow Generator (image Viasys Healthcare) 
 
Fluidic flip: 
The principle of the fluidic flip is a phenomenon known as the Coanda 
Effect. The Coanda effect is the tendency of a fluid jet to be attracted to 
a nearby surface. When a jet of fluid leaves a nozzle at high speed, fluid 
from the body that it enters is entrained, or drawn in, by the momentum 
of the flow. If there is an obstruction to this action, such as a wall, there 
is less fluid to be drawn in with a resulting drop in pressure on one side 
of the jet. This pressure drop causes a deflection in the flow and 
redirects the jet until it attaches to the wall. The Infant Flow CPAP 
generator demonstrates this effect by utilising the baby’s breathing 
effort to induce the Coanda Effect and trigger Fluidic Flip inside the 
device. NCPAP is maintained at the nasal connection throughout the 
breathing cycle and flow will be redirected to the expiratory limb during 
expiration (Fig.4). When the expiratory breathing effort stops, the flow 
instantly flips back to the inspiratory position.   
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Fig.4: Fluidic flip (Image Viasys Healthcare Inc.) 
 
 
1.4.2 Effects on lung mechanics 
The effects of CPAP on lung mechanics are influenced by the 
underlying pathology and maturity of the respiratory system, staff 
expertise and the CPAP device used. Several authors have 
investigated the effects of CPAP. The variety of diseases, disease 
severity, study design, CPAP modalities and lung function testing 
equipment utilized in these studies make comparison of the findings 
difficult.  
 
However in general it was found that the administration of CPAP 
improves lung volume (25;57;58) and oxygenation (59), decreases work 
of breathing (58;60) and respiratory rate (61;62), prolongs expiratory 
time (63), reduces apnoea (64), splints the upper airway (65) and 
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improves thoraco-abdominal synchrony by increasing chest wall 
stability (66).  
 
Furthermore, CPAP provokes the Hering-Breuer inflation reflex by 
increasing lung volume and therefore stimulating pulmonary stretch 
receptors, which via neural pathways regulates duration of inspiration 
and expiration (61).  
 
The following sections summarise the effects of different CPAP levels 
on selected parameters and emphasise in particular the effects of the 
Infant Flow System on lung mechanics. 
 
 
1.4.2.1 Effects on work of breathing  
Pandit et al. (67) investigated the effects of different CPAP devices 
(variable vs. continuous flow) on respiratory muscles in 24 preterm 
infants at 14 days of age. All subjects received CPAP for mild to 
moderate respiratory distress with a fraction of inspired oxygen of less 
or equal than 0.3. CPAP levels ranged from 0 to 8 cmH2O with an 
adjustment period for each level of 3 to 5 minutes. Lung mechanics 
were measured via oesophageal balloon catheter and respiratory 
inductance plethysmography. Twenty to 30 breathing cycles were 
recorded and work of breathing was estimated by calculating the area 
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within the pressure volume loop (Campbell’s diagram). Lower work of 
breathing for the variable flow device was reported. Furthermore, it 
seemed that resistive work of breathing decreased and inspiratory work 
of breathing increased with the variable flow device in proportion to 
applied pressure levels. No further comments were made in regards to 
changes of work of breathing between CPAP levels. It also remains to 
be debated if the results can be reproduced in a clinical setting with 
longer duration of nCPAP treatment. 
 
 
1.4.2.2 Effects on breathing pattern as derived by  
               respiratory inductance plethysmography 
The effect of different CPAP levels on respiratory rate was investigated 
in five studies. Ninety three subjects were studied ranging from 10 to 32 
per study. All studies reported data from preterm infants (gestational 
age ranging from 26 to 32 weeks) with a chronological age ranging from 
10 hours to 12 days. Although there were differences in CPAP devices 
used, administration of surfactant and severity of lung disease, most 
studies reported a decrease of respiratory rate in proportion to  applied 
CPAP levels (35;37;67;68).  One study reported no significant change 
in respiratory rate but a downward trend with increased CPAP levels 
was observed (69).    
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Expiratory time was measured in two studies. 27 preterm infants were 
studied at a chronological age of 10 hours up to 12 days. Subjects 
received CPAP for respiratory distress syndrome or moderate 
respiratory failure. All studies reported an increase in expiratory time in 
proportion to the applied CPAP levels (ranging from 0 to 10 cmH2O) 
(35;37). It was thought that nCPAP eliminates the dynamic elevation of 
FRC, an energy consuming breathing strategy of the neonate to 
increase lung volume and improve oxygenation. Loss in this dynamic 
elevation of FRC was associated with lengthening of expiratory time 
and with shortening of the time-constant of the respiratory system.  
 
Thoraco abdominal asynchrony as measured by the phase angle was 
investigated in three studies. The number of subjects ranged from 10 to 
11 with a total of 31 subjects. The gestational age ranged from 26 to 32 
weeks and the chronological age from 1 to 22 days. CPAP was applied 
at different pressure levels ranging from 0 to 8 cmH2O. All studies 
reported a decrease in phase angle from baseline to 6 or 8 cmH2O 
(37;66;69). It was thought that nCPAP stabilised the highly compliant 
chest wall of the neonate reducing inward movement during inspiration 
and therefore decreasing thoraco abdominal asynchrony. This leads to 
a more efficient and less energy consuming breathing. 
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1.4.2.3 Effects on other clinical parameters 
The effect of different CPAP levels on indices of oxygenation and 
ventilation were investigated in six studies. The number of subjects 
ranged from 10 to 32 with a total of 86 subjects. The gestational age 
ranged from 26 to 32 weeks and the chronological age ranged from 12 
hours to 12 days. CPAP was administered via ETT, nasal prongs and 
infant flow system. Oxygen requirement ranged from FiO2 < 0.3 to 1. 
Furthermore, different indices of oxygenation / ventilation were 
measured. Three studies described an improvement in PaO2 
(57;70;71). Two studies reported no change in transcutaneous CO2 and 
transcutaneous O2 measurements (37;69). One study reported an 
increase in PaCO2 below and above “optimal” CPAP as defined as the 
CPAP level with the lowest aADCO2 (arterial alveolar diffusion of CO2) 
(72). The effect of CPAP on haemodynamics was investigated in four 
studies. The number of subjects ranged from 10 to 32 with a total of 70 
subjects. Preterm infants at a chronological age ranging from 10 hours 
to 8 days were studied. No changes in heart rate (68), blood pressure 
(37;69) and cardiac output (73) was reported, even at higher CPAP 
levels of 7 to 8 cmH2O. 
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1.4.2.4 Effects of the infant flow system on lung  
   mechanics 
The effect of CPAP depends to a great extend on the device used. Only 
a few studies (37;67;69) investigated the effect on lung mechanics in 
neonates receiving nCPAP via the Infant Flow system. Table 1 
summarises nCPAP effects on selected parameters, which are relevant 
to my study.  
 
 
Table 1: Summary of effects of the Infant Flow System  
Parameters CPAP effects No of studies 
Thoraco abdominal 
asynchrony 
↓ 3 
Lung volume  ↑ 3 
Respiratory rate  ↓/→ 2 
Expiratory time  ↑ 1 
Transcutaneous O2, 
transcutaneous CO2 
→ 2 
Mechanism CPAP effects No of studies 
Dynamic elevation of FRC eliminates 1 
 
WOB=work of breathing, Vt = tidal volume, FRC = functional residual capacity,  
↑= increase, ↓= decrease, → = no change 
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1.5 “Optimal” CPAP  
Few studies investigated the “optimal” level of CPAP.  
CPAP at different pressure levels ranging from 0 to 8 cmH2O was 
applied via Infant Flow System in 2 studies (37;69). Other studies 
applied CPAP via endotracheal tube or nasal prongs at different 
pressure levels ranging from 0 to 16 cmH2O (35;70;72) .  Different 
parameters were investigated, but all studies reported the “best” values 
including, longest expiratory time, minimal thoraco-abdominal 
asynchrony as measured by phase angle, sudden increase in lung 
compliance as measured by transpulmonary pressure, largest end 
expiratory lung volume, lowest a-ADCO2 or PCO2 at higher CPAP levels 
(Table 2).  
Bonta in 1977 (70) investigated the use of oesophageal pressure to 
optimise CPAP therapy in 10 neonates. It was assumed that at 
“optimal” CPAP, PaO2 increases dramatically due to recruitment of 
previously collapsed alveoli, which is associated with an increase in 
FRC.  It was thought that a change in FRC should be reflected in a 
change in pleural pressure, which is detectable by measuring changes 
in oesophageal pressure. CPAP was applied by nasal prongs in six and 
ET tube in four neonates of which four developed a pneumothorax. A 
rapid increase in Poe, Poe/Pao and PaO2 at “optimal” CPAP level 
(8.1±0.8 cmH2O) was reported, reflecting an increase in FRC and lung 
compliance.   
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Other studies (35;37) reported that CPAP eliminates the energy 
consuming dynamic elevation of FRC. This was associated with a 
marked prolongation of expiratory time (35;37;69) and shortening of the 
time-constant of the respiratory system (37). Elevation of CPAP beyond 
this level produced a rapid, shallow breathing often combined with flow 
acceleration late in expiration (recruitment of expiratory muscles), 
possibly due to over distended lungs. In some neonates this 
phenomenon already occurred at the lowest CPAP levels.  It was found 
that the higher the baseline respiratory rate the higher the CPAP level, 
inducing a maximum prolonged expiratory time (35). A higher baseline 
respiratory rate might have indicated a more severe lung disease 
requiring more pressure support.  
 
Mulrooney in 2005 (74) investigated the relationship between the 
amount of surfactant and the effects of CPAP and mechanical 
ventilation on lung mechanics and lung injury. Bubble CPAP was 
administered via ET tube to preterm lambs.  After initial application of a 
CPAP level of 8 cmH2O, lambs were randomised to receive either 5 or 
continue at 8 cmH2O.  It was reported that after 6 hours the PO2/FiO2 
improved, respiratory rate and minute ventilation decreased in the 
group receiving CPAP at 8 cmH2O. There was no change in PCO2. It 
seemed that higher CPAP level promoted better oxygenation and more 
efficient breathing.   It was speculated that CPAP at higher levels 
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improved FRC and lung mechanics. The authors suggested re-
evaluating current CPAP strategies for infants with respiratory distress 
syndrome. 
 
Despite the findings of those studies, the “optimal” level of nCPAP 
according to the respiratory condition treated and individual respiratory 
demands remain to be determined (75-78).  
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Table 2: “Optimal” CPAP 
 
Authors 
 
Subjects 
 
N 
 
Respiratory Status 
 
Surfactant 
 
CPAP Devices/ Pressure 
Ranges 
 
Parameter 
 
“Optimal” CPAP 
cmH2O 
 
Bonta 
1977 
 
preterm 
CA 12h 
 
 
10 
 
RDS 
FiO2 ≤ 0.77 
 
 
no 
 
4x via ETT 
6x via nasal prongs 
4-10cmH2O 
 
 
Ptp 
 
 
8.1 
 
Landers 
1986 
 
preterm 
CA<72h 
 
 
 
11 
 
HMD 
FiO2 0.6-1 
 
 
no 
 
via ETT 
up to 8-16 cmH2O 
 
a-ADCO2 
PCO2 
 
8.9±0.9 
6.2±1.6 
 
Schulze 
1990 
 
preterm 
CA 10-72h 
 
 
16 
 
 
RDS 
 
 
no 
 
4x via ETT 
nasal prongs 
0.2-1kPa 
 
 
Te 
 
 
Not stated 
 
Elgellab 
2001 
 
preterm 
CA 1-2d 
 
 
 
10 
 
 
FiO2 ≤ 0.3 
 
 
7 x yes 
 
Infant flow 
0-8cmH2O 
 
Te, Vt, EELV, 
PA 
 
 
8 
 
Magnenant 
2004 
 
preterm 
CA12d 
 
 
11 
 
 
FiO2 ≤ 0.3 
 
 
yes 
 
Infant flow 
0-6cmH2O 
 
 
Te, Vt, PA, RR 
 
 
6 
 
Mulrooney 
2005 
 
preterm lambs 
CA 132d 
 
 
16 
  
 
yes 
 
Bubble CPAP 
5 and 8cmH2O 
 
PO2/FiO2 
RR, VE 
 
 
8 
CA = chronological age, h = hours, d = day, FiO2=fraction of inspired oxygen, aADCO2 – arterial alveolar diffusion of CO2, PA = phase angle,  
Ptp = transpulmonary pressure, Te = expiratory time, EELV = end expiratory lung volume, RWOB – resistive work of breathing,  
iWOB = inspiratory work of breathing, HMD=Hyaline membrane disease, RDS=respiratory distress syndrome, VE=minute ventilation
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1.6 Adverse effects 
Several adverse events related to CPAP have been reported including 
pneumothoraxes (79), apnoea at sudden pressure loss (59), increased 
intestinal blood flow (80), decreased urine output at higher CPAP levels, 
increased urine osmolality (81) and nasal deformities (82).  
 
The function of the major respiratory muscle, the diaphragm, was 
investigated in one study when nCPAP was applied at low, medium and 
high pressures levels. Diaphragm thickness increased from low to high 
and diaphragmatic excursion decreased from low to high nCPAP levels 
(71). The findings suggest that diaphragmatic function may become 
impaired at higher CPAP levels.  
 
Furthermore, there are concerns that the administration of higher 
nCPAP levels increase the risk of pneumothorax. An increased 
incidence of pneumothorax was reported in the COIN trial (83). This 
randomised trial investigated whether nCPAP, rather than intubation 
and ventilation, shortly after birth would reduce the rate of death or 
bronchopulmonary dysplasia in very preterm infants. In that trial, CPAP 
was initiated at 8 cmH2O and then adjusted according to the study 
protocol. The incidence of pneumothorax was 9% in the nCPAP group 
versus 3% in the intubation group. The authors did not administer 
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surfactant to the patients in the nCPAP group, which might be a 
possible explanation for the high incidence rate.  
 
Questions have also been raised concerning the possibility that nCPAP, 
especially at higher pressure levels, may decrease venous return and 
cardiac output. A recent study by Moritz et al. (73) reported no changes 
in cardiac output in neonates receiving nCPAP up to 7cmH2O. 
However, the concern amongst clinicians in regard to cardiac 
decompensation at higher levels of nCPAP remains. 
 
 
1.7 Outcome of nCPAP treatment 
The lack of randomised controlled trials and a standardised definition of 
nCPAP failure make it difficult to comment on the outcome of nCPAP 
treatment.  
 
Several authors reported a reduction, in mortality (84), respiratory 
failure (84) and extubation failure (76). A retrospective study in 
Germany noticed a reduction in bronchopulmonary dysplasia (BPD) 
between 18-55% in infants >1000g and between 30 to 90% in infants 
<1000g as well as a reduction in ventilation days. The authors also 
noticed a reduction in the use of intravenous lines, drugs, steroids and 
antibiotics (85). Morley et al. (79) did not show any change in mortality 
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or incidence in BPD comparing early use of nCPAP versus mechanical 
ventilation. Although a reduction in ventilation days and oxygen 
requirement at 28 days was noticed. The authors concluded that CPAP 
seems to be more successful in infants of more than 750g. Whether 
nCPAP reduces the incidence of BPD remains debated. 
 
 
1.8 Current practice 
To our knowledge there are no evidence based guidelines for the 
initiation and titration of nCPAP.  Common practise is to start at 4-5 
cmH20 and then titrate up to 7-8 cmH2O against clinical signs of 
respiratory distress or FiO2 (86).  
 
 
1.9 Work of breathing 
Although several studies investigated the effect of CPAP on lung 
mechanics, the question that remains to be answered is, against what 
parameter should nCPAP be titrated?  
 
The overall aim of nCPAP is to improve gas exchange and either 
prevent or treat respiratory muscle fatigue.   
Respiratory muscle work load is thought to be an early indicator of 
respiratory muscle fatigue and respiratory muscle disuse atrophy. 
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Titrating nCPAP against indicators of respiratory muscle work load, also 
known as work of breathing, might therefore be a logical/useful strategy 
(87). Titrated nCPAP might decrease nCPAP failure rates, the need for 
mechanical ventilation and its associated complications including 
nosocomial infections improve weaning strategies and reduce energy 
expenditure due to increased respiratory muscle work load. The 
cumulative effects of all of this might be an improvement in infant 
growth and a reduction in morbidity.  
 
Assessment of work of breathing (WOB) is useful in the field of 
mechanical ventilation, and has contributed to important progress, in 
the management of patients, in optimising and understanding the 
effects of ventilator settings such as trigger, external positive end 
expiratory pressure and peak inspiratory flow. Assessment of work of 
breathing has also been used to evaluate the physiological effects of a 
number of agents such as helium and bronchodilators. Studies in this 
area have given greater insight into the pathophysiology of ventilator 
weaning failure and have also contributed to the progress made in the 
field of non-invasive ventilation (88).  
 
The work of breathing has been defined as the work necessary to 
overcome the after load imposed on the respiratory system (89).  This 
work is performed by the respiratory muscles (predominantly intercostal 
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muscles and diaphragm) during spontaneous ventilation, by the 
ventilator during controlled ventilation, or by both during partial 
ventilatory support.  When applied to the respiratory system, work is 
performed when pressure (force divided by area) changes the volume 
of the system: 
 
 
Elastic WOB is work performed on the tissue of the lung and chest wall 
when a change in volume occurs.  
Flow-resistive WOB is work performed to overcome airway, tissue and 
viscous resistance to gas flow (90). 
 
In 1958 Campbell (91) published a method of measuring the 
mechanical work of breathing in a spontaneously breathing subject. 
This was based on earlier work of Roher and Fenn (92). The method 
involves the construction of a pressure-volume diagram (“The Campbell 
diagram”) and calculation of its enclosed area. Since then several 
indicators of work of breathing have been investigated including the 
pressure time product (PTP).  It is thought that PTP reflects the oxygen 
and metabolic cost of breathing  (45) and has gained acceptance as a 
useful tool for evaluation of breathing efforts in critically ill patients. 
Recently, measurements of electrical activity of the respiratory muscles 
work = pressure x volume 
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have been investigated. A full review of this topic is however, beyond 
the scope of this thesis.  
 
 
1.9.1 Work of breathing in clinical practise 
This section will give a short overview of studies that measured WOB in 
order to optimise ventilation strategies (Table 3).  
 
Four studies investigated the effect of different modes of ventilation and 
ventilation settings, on work of breathing as measured by the 
oesophageal pressure time product in infants.  
 
Takeuchi et al. (93) investigated different ventilator settings in infants 
after cardiac surgery and reported an increase in work of breathing 
when PTV (patient triggered ventilation) was reduced and described a 
positive correlation between work of breathing with respiratory rate and 
thoraco abdominal asynchrony.  
 
Imanaka et al. (94) reported an increase in work of breathing when 
SIMV (synchronised intermittent ventilation) rate was reduced, but 
clinical respiratory parameters were not recorded. In infants with upper 
airway obstruction application of NIMV (non-invasive mechanical 
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ventilation) reduced work of breathing which correlated with clinical 
signs of upper airway obstruction (95).  
 
Only one study (87) investigated the effects of nCPAP on work of 
breathing and reported a more than 50% reduction in WOB when 
nCPAP was applied to infants with bronchiolitis. The authors described 
a good correlation with the Wood’s Asthma score.   
 
The effect of different modes of ventilation (continuous positive airway 
pressure vs. pressure support ventilation) on work of breathing as 
measured by the oesophageal pressure time product was previously 
more extensively investigated in adults with acute respiratory failure. It 
was found that in comparison to pressure support ventilation, work of 
breathing increased in the CPAP mode.  Respiratory parameters were 
compared with measurements of work of breathing and it was found 
that respiratory rate explained 22%, tidal volume 27% and breathing 
pattern score (consisting of sternocleidomastoid activity, respiratory 
rate, abdominal paradox, sternal recession and tidal volume) 43 % of 
the variance of oesophageal pressure time product (96).  
 
Manczur et al. (97) compared different weaning strategies from 
mechanical ventilation and reported that work of breathing was lower in 
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SIMV, compared to CPAP mode, and should therefore be the mode of 
choice during weaning of mechanical ventilation. 
 
In summary, measurements of work of breathing might be useful in 
optimising ventilation strategies. Those measurements are invasive and 
attempts have been made to identify non-invasively determined 
predictors of work of breathing. It remains unclear though what 
respiratory parameters might be best to predict work of breathing in 
various respiratory conditions.
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Table 3: Studies investigating the clinical application of work of breathing  
Authors N Mode of Ventilation subjects WOB 
(PTPoe) 
Clinical parameter 
 
Banner 
1995 
 
67 
 
 
CPAP vs. PSV 
Adults 
ARF 
 
↑ RR↑, Ti/Ttot ↑, Vt ↓ 
breathing pattern score  
(poor predictors of WOB) 
 
Takeuchi 
2000 
 
7 
 
 
↓PTV 
1-11months 
post cardiac 
surgery 
 
↑ 
 
RR↑, MCA/Vt ↑ 
Manczur 
2000 
40 
 
 
CPAP vs. SIMV 
14months  
prior to extubation 
↑ 
 
 
Not recorded 
 
Imanaka 
2001 
 
11 
 
 
↓SIMV rate 
7 months 
post cardiac 
surgery 
 
↑ 
 
Not recorded 
 
Cambonie 
2008 
 
 
12 
 
 
nCPAP 
 
2 months 
bronchiolitis 
 
↓ >50% Wood’s asthma score ↓ 
(good correlation with WOB) 
NCPAP = nasal continuous positive airway pressure, PSV = pressure support ventilation, PTV = patient triggered ventilation, SIMV 
= synchronised intermittent ventilation, RR = respiratory rate, Vt = tidal volume, Ti/Ttot, inspiratory time/total breathing time, WOB = 
work of breathing, MCA/Vt = maximum compartment amplitude over tidal volume, ARF=acute respiratory failure
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1.10 Equipment 
The following sections will describe the equipment used in my study to 
measure work of breathing and other respiratory parameters. 
 
 
1.10.1 Oesophageal Gastric Manometry  
Oesophageal gastric manometry is a well established technique for 
evaluation of respiratory muscle work load (98).  A description of 
different techniques is outside the scope of this thesis and only details 
of the equipment used in this study are provided.   
The pressure transducer is a catheter with two sensors at the distal end 
(Fig.5) Those pressure sensors are solid state sensors made of 
piezoelectric material. Piezoelectric material is a neutrally charged 
crystal, which changes its polarity if a force/pressure is applied, creating 
an electrical current.  These sensors detect pressure changes in the 
last third of the oesophagus and stomach reflecting pressure changes 
in the pleural space (99;100) and abdominal compartment (98). The 
pressure changes are caused by contractions of the respiratory 
muscles (including ribcage muscle, diaphragm and abdominal muscles) 
throughout the breathing cycle.  
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To determine the position of the sensor in the last third of the 
oesophagus an occlusion test is performed. These occlusion 
manoeuvres (101;102) result in a brief respiratory pause if the Hering-
Breuer Inflation Reflex can be induced. When the infant’s airway is 
occluded above functional residual capacity, stretch receptors in the 
chest wall are activated, leading to a short apnea and relaxation of the 
respiratory muscles. The pressure can equilibrate such that the airway 
opening pressure reflects the pressure within the alveoli. During 
occlusion it is assumed that the pressure throughout the whole 
respiratory system equalises and therefore a change in pleural pressure 
(∆Pl) equals a change in airway opening pressure (∆Pao)(103).  
Therefore if the catheter is in the right position:   
 
     
∆Poe = change in oesophageal pressure, ∆Pao = change in airway opening pressure 
 
 
 
Catheter 
 
 
 
 
 
Pressure sensors 
 
 
 
Fig.5: Illustration of the placement of an oesophageal gastric catheter (one pressure 
sensor is placed in the last third of the oesophagus and the other sensor in the 
stomach (photo: Benditt Respiratory Care 2005). 
∆Poe = ∆Pao (1 ± 0.05) 
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Once the catheter is placed in the correct position pressure signals are 
continuously recorded and work of breathing can be calculated by 
integrating the area under the pressure curve, the so called pressure 
time product (Fig.6).   
 
 
 
 
 
 
 
 
 
 
Fig.6: Illustration of the calculation of oesophageal and gastric pressure time product, 
Pga = gastric pressure, Poe = oesophageal pressure, PTPga = gastric pressure time 
product, PTPoe = oesophageal pressure time product. 
 
 
 
Oesophageal gastric manometry is a relatively invasive technique and 
is currently not used in clinical practise. The following section describes 
an alternative non-invasive method to measure lung mechanics in 
neonates that may be suitable for bedside use.  
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1.10.2 Respiratory inductance plethysmography  
Rib cage and abdominal movements are recorded by utilizing non-
invasive respiratory inductance plethysmography (RIP). The device 
consists of two light-weight transducers made of elastic polyester bands 
(2.5 cm in width) with sinusoidal coils of Teflon-insulated wire 
embedded within them. The transducer bands are placed around the 
ribcage at the level of the nipple line and around the abdomen 0.5 cm 
above the umbilicus.  Changes in the cross sectional areas of the 
ribcage and abdominal compartments alter the self-inductance of the 
coils and the frequency of their oscillations  
  
 
 
 
 
 
Fig.7: Illustration of thoraco abdominal asynchrony in infants (photo: 
Sweet Haven Publishing Services) 
 
 
Measurements of thoraco abdominal asynchrony (Fig.7) are often used 
as an indicator of respiratory distress. Thoraco abdominal asynchrony 
or paradoxical breathing, occurs if the rib cage is sucked in or retracted 
as abdominal excursions occur (i.e. diaphragmatic contractions in 
compliant chest wall), or if the abdomen is retracted as the rib cage 
expands (i.e. diaphragmatic paralysis), or when respiratory muscles are 
activated at different times (i.e. immaturity of the respiratory system) 
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during the breathing cycle. Thoraco abdominal asynchrony is often 
observed in infants with various forms of respiratory diseases including 
upper airway obstruction, lung parenchymal disease (i.e. pneumonia, 
oedema), obstructive lower airway disease (asthma, respiratory distress 
syndrome, bronchopulmonary disease) and neuromuscular diseases.  
 
Respiratory inductance plethysmography can be used to detect and 
measure thoraco abdominal asynchrony by phase angle analysis (104). 
The phase angle is the fraction of a cycle measured in degrees when 
comparing two simultaneous periodic wave forms. The given value is 
normally zero for two synchronous waves. The more asynchronous the 
breathing the larger is the phase shift (Fig.8).  
 
 
 
 
 
 
 
 
Fig.8: Phase shift (phase angle) between ribcage (RC) and abdominal (AB) waves 
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In summary 
Assessment of pulmonary function in neonates on nCPAP is often left 
to clinical judgement, which is subjective and may be inadequate. 
Indices of oxygenation and respiratory rate are the only measures that 
are widely recorded but their suitability to guide ventilator therapy is 
limited. Optimal nCPAP levels and what parameter to titrate nCPAP 
against, still remains to be determined. Quantitative measurements of 
respiratory muscle work load, have contributed to the progress made in 
mechanical ventilation and weaning and might also be useful to guide 
nCPAP therapy.  
 
 
1.11 Study rational 
This is the first study investigating changes in respiratory muscle work 
load of rib cage muscles, diaphragm and abdominal muscles at different 
levels of nCPAP in neonates and correlating those invasive 
measurements of work of breathing with respiratory parameters derived 
by non-invasive techniques. 
 
Reducing the work of breathing might improve ventilatory support by 
avoiding respiratory muscle fatigue and respiratory muscle disuse 
atrophy. Additionally it might reduce energy expenditure, promoting 
weight gain and general development of the preterm infant and reduce 
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the need for mechanical ventilation leading to a reduction in nosocomial 
infection, patient morbidity, hospital stay and cost. 
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2  Methods and Materials 
 
2.1 Hypotheses 
Null Hypotheses 
H0: Respiratory muscle work load as measured by the pressure time 
product is not affected by changes in the level of nasal continuous 
positive airway pressure and does not correlate with changes in clinical 
parameters (respiratory rate, fraction of inspired oxygen and heart rate) 
and parameters derived by Respiratory Inductance Plethysmography 
(phase angle, abdominal excursion and expiratory time). 
 
Alternative Hypotheses 
H1: Respiratory muscle work load as measured by pressure time 
product is affected by changes in the level of nasal continuous positive 
airway pressure.  
 
H2: Changes in phase angle and expiratory time derived by non-
invasive respiratory inductance plethysmography correlate with 
changes in pressure time product derived by oesophageal gastric 
pressure transducer at different levels of nasal continuous positive 
airway pressure. 
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H3: Reduction of pressure time product correlates with improvement of 
clinical parameters (heart rate, respiratory rate, fraction of inspired 
oxygen and peripheral oxygen saturation). 
 
 
2.2 Aim and objectives 
The overall aim of the study was to investigate if work of breathing as 
measured by invasive techniques can be predicted by respiratory 
parameters derived by non-invasive techniques.  
 
The objectives were: 
1. To develop a monitoring system for the measurement of work of 
breathing in neonates on nCPAP. 
2. To validate the new monitoring system.  
3. To measure changes in pressure time products at different levels of 
nCPAP. 
4. To determine the correlation between pressure time product derived 
by oesophageal gastric pressure transducer and phase angle and 
expiratory time derived by respiratory inductance plethysmography 
at different levels of nCPAP. 
5. To determine whether there is a correlation between pressure time 
product and clinical parameter including respiratory rate, fraction of 
inspired oxygen, peripheral oxygen saturation and heart rate. 
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2.3 Project overview 
The project development will be described in the next sections. Fig.9 
illustrates the different steps of the project and input from different 
disciplines.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.9: Illustration of different steps throughout the project 
 
 Ethics and Funding   
Study design 
Hardware 
Software  
Validation 
Data analysis 
Bioengineer
 
Statistician 
Data collection 
Statistical analysis 
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2.4   Ethics and Funding 
Ethics approval was obtained from both centres where the research 
was performed (St Mary’s Hospital NHS Trust and Tygerberg Children’s 
Hospital, University of Stellenbosch, South Africa). Written informed 
consent was obtained from the parents or legal guardians. Patient 
information sheets and consent forms were translated into Xhosa and 
Afrikaans. If required, an interpreter was available at any time. All 
investigations have been conducted to the best of our knowledge 
according to the Declaration of Helsinki. 
The study was funded by the “Save the Baby” and “Sydney and Phyllis 
Goldberg “Charitable Trust. 
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2.5 Description of population and environment 
The study took place in a limited resource setting at the neonatal unit at 
Tygerberg Hospital, Cape Town, South Africa. The hospital serves 
mainly no - or low-income inhabitants from poor socioeconomic 
circumstances.  
 
The catchment area in the Cape Town metro houses 2.5 million 
inhabitants and the surrounding per urban and rural referral areas has a 
further 60 000 inhabitants. Around 12363 babies weighing > 500g are 
delivered annually at Tygerberg Hospital; 26% of mothers are HIV 
infected 10% use crystal-methamphetamine and 50% smoke during 
pregnancy. Preterm labour occurs in 20% of deliveries of which 29% 
are low birth weight, 7.6 % are very low birth weight and 2 % are 
extreme low birth weight infants. 
 
The neonatal unit has 110 cots of which 8 are intensive care cots. 
There are 7524 infants >500g admitted per year. Only babies requiring 
intermittent positive pressure ventilation are admitted to intensive care, 
infants receiving non-invasive ventilation are admitted to wards where 
both in/out surfactant and nCPAP via infant flow driver can be offered. 
Annually, approximately 500 newborn babies require nCPAP of which 
80 per year are unsuccessful and move on to mechanical ventilation or 
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die. At 36 weeks corrected age 1% of this cohort is diagnosed with 
chronic lung disease of prematurity. 
 
Unit policies: 
Due to limited resources admission criteria to the NICU are as follows: 
• Babies born at Tygerberg Hospital weighing > 800g and with a 
gestational age of > 27 weeks 
• Babies born outside Tygerberg hospital weighing > 1000 grams 
and with a gestational age of > 28 weeks 
 
All infants are offered nCPAP (Neopuff device) in labour ward / delivery 
room and during transition period. If breathing is established, but there 
are any signs of respiratory distress, nCPAP is continued on the ward 
and set at 5 cmH2O. 
 
In the wards the following patients are eligible for in and out surfactant 
(Porcine or Bovine) with continued ventilatory support with nCPAP 
• Birth weight > 800g and /or gestational age > 26 weeks and 
• FiO2 ≥ 0.35 
 
Weaning from nCPAP is commenced after significant response to initial 
nCPAP, with or without Surfactant treatment.  Once the baby is in 0.21 
FiO2 the pressure is weaned by 1cmH2O every 4 hours until 2 cmH2O. If 
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there is no increase in FiO2, the patients are either put into room air or 
switched to nasal cannulae low flow oxygen at 2L/min and weaned 
according to clinical picture.  
Infants with apnoea or respiratory deterioration not yet requiring 
intubation are also offered nCPAP in the neonatal wards. 
 
 
2.6 Study eligibility criteria 
Eligible were neonates with a weight of 500g or greater who required 
nCPAP. Excluded were neonates diagnosed with a major congenital 
malformation, haemodynamic instability, necrotising enterocolitis, 
pneumothorax and who required a FiO2 more than 0.6. Discontinuation 
criteria were an increase in spontaneous respiratory rate by 20% from 
baseline, single episode of apnoea more than 15 seconds, more then 
one episode of apnea with arterial desaturation, heart rate increase of 
more than 20% from baseline or persistent bradycardia (<100/min) 
warranting intervention, need for urgent clinical intervention or any 
unexplained or any unexpected deterioration in the patient’s condition, 
responsible clinician decided to stop study, or if consent was withdrawn.
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2.7 Interventions and measurements 
Each participant received nCPAP at pressure levels of 2, 4, 6 and 8 
cmH2O. The sequence of the pressure levels for each subject was 
randomised to avoid a “volume history effect” (an increase of lung 
volume with increased CPAP).   
 
Lung function parameters were continuously measured at each CPAP 
level via Respiratory Inductance Plethysmography (RIP) and 
oesophageal gastric pressure transducer. Measured parameters were 
oesophageal pressure, gastric pressure, phase angle, abdominal 
excursion, expiratory time, respiratory rate, fraction of inspired oxygen 
and heart rate.  
 
 
2.8 Equipment  
A data acquisition system was built consisting of, catheter tip pressure 
transducer (Gaeltec Ltd), Respiratory Inductance Plethysmography 
(Respitrace plus, Viasys Healthcare Inc.), a respiratory monitor 
(CO2SMO Plus, Philips-Respironics), specialised programmed Lab 
VIEW software (SSDC, National Instrument) for data capture and 
specialised programmed excel software (Cape Biotech, Microsoft Excel) 
for data analysis.  
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2.8.1 Equipment set up 
The modified data acquisition unit (Fig.10 and 11) received analogue 
signals from the pressure transducer and Respitrace bands. Those 
signals were directed to a personal laptop and converted to digital 
signals. A respiratory monitor, measuring SpO2, heart rate, flow and 
airway opening pressure, was connected to the same laptop. The Infant 
Flow Generator was connected to the respiratory monitor, allowing 
continuous recordings of pressure levels. The equipment was 
connected via patient isolation transformer to the mains. The original 
Respitrace plus software and the respiratory monitor software was 
replaced by specialised programmed LabVIEW software to achieve 
time synchronised  signals from different sources and allow real time 
graphic display of the data. The sampling rate of the equipment was 
100 Hz. 
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Fig.10: Equipment set up on the neonatal high care unit (Tygerberg 
Hospital), Left: Trolley with data acquisition units, Right: Infant Flow System, Middle: 
patient connected to equipment   
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
Fig.11: Diagram of equipment set up 
Respitrace and data 
acquisition unit 
Amplifier 
Laptop 
Infant 
Flow 
Isolation 
Transformer 
Catheter  
 
Patient 
Respiratory monitor 
Mains 
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2.8.2 Oesophageal gastric pressure transducer  
The pressure transducer (Gaeltec Ltd) (Fig.12) was made of a flexible 
silicone rubber. In free air or water, the resonant frequency of the 
pressure sensors is in the region of 12 KHz. The catheters were of 
different length, diameter and different sensor spacing according to the 
subject’s weight. A feeding tube was incorporated into bigger catheters 
(6FR) for patients with a weight of more equal then 1.5 kg. A smaller 
catheter (4FR) was used for patients with a weight less then 1.5 kg. 
(See appendix page 171 for technical specifications.) 
 
  
Feeding tube 
 
Catheter  
Connector to extension lead    
            Pressure sensors 
 
 
Fig.12: Oesophageal gastric pressure transducer  
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2.8.3 Respiratory inductance plethysmography 
Respitrace bands (Fig.13) were placed around chest and abdomen and 
connected to the data acquisition unit (Fig.14). 
 
 
 
 
 
 
Infant flow 
 
Respitrace band 
 
Catheter 
 
 
 
 
Fig.1: Respi bands and oesophageal gastric pressure  
transducer in situ  
 
 
 
 
 
 
 
 
Fig.14: Respitrace data acquisition unit 
 
 
 
 
71 
 
2.8.4 Respiratory Monitor  
Flow measurements in the CO2SMO plus (Fig.15) were made using a 
fixed orifice differential pressure transducer. Respired gas passing 
through the flow sensor (Fig.16) causes a small pressure drop across 
the two tubes connected to the sensor. This pressure drop is 
transmitted through the tubing to a differential pressure transducer 
located inside the monitor and is correlated to flow according to the 
factory stored calibration. The pressure transducer is automatically 
“zeroed” to correct for changes in ambient temperature and electronics. 
Peripheral oxygen saturation and heart rate were measured via pulse 
oximetry. (See appendix page 171 for technical specifications) 
 
 
                           To monitor              
 
 
 
 
 Patient side, 
 connected 
to face mask                  
 
 
Fig.15: CO2SMO plus respiratory monitor   Fig.16: Flow sensor 
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2.8.5 Infant Flow System  
CPAP was applied via nasal prongs (infant flow generator). The nasal 
prongs were securely applied onto the subject’s nose and held in place 
via strings and tape, which were connected to a hat to avoid leaks 
especially at higher CPAP levels (Fig.13). The neonatal unit used a 
custom made CPAP driver (Fig.17) by Viasys Healthcare Inc. Pressure 
was indicated by a diaphragm pressure gauge and adjusted via air flow. 
The respiratory monitor was connected via a y-piece proximal to the 
pressure gauge allowing recording of applied pressure.  
                                                                                                         
 
Pressure dial 
 
 
 
Y-piece  
 
 
 
 
Oxygen adjustment 
 
Flow adjustment 
 
 
 
 
 
 
Humidifier 
 
Fig.17: Custom made Infant Flow Driver (Viasys Healthcare Inc.) 
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2.8.6 Software for data collection  
The software for the system was developed in collaboration with SSDC 
Ltd by utilizing National Instruments LabView 8.2 Professional, a 
graphical user interface for rapid software development. LabView has a 
graphical representation of the source code rather than lines of text.  
The software incorporates large resources of data manipulation and 
measurement algorithms. By making use of a number of these it is 
possible to develop complex data acquisition and control applications. 
The data acquisition system measures parameters and passes the data 
on to an integral serial port for transfer to the host laptop. There are two 
input channels for measuring strain, which are connected to the 
Respitrace bands.  Additionally there are two pressure input channels, 
which accept inputs from a catheter measuring oesophageal and gastric 
pressure. The serial port is set to run in free-run mode. There is no 
intervention from the host PC and data is generated by the data 
acquisition unit. A LabVIEW driver for the Respitrace unit was 
developed so that data appearing on the serial bus could be imported to 
the host application. The system was connected to the laptop via its 
integral RS232 serial port. An instrument driver was also developed for 
the CO2SMO Plus respiratory monitor so that the required functions 
could be controlled from the host application. The main operation of the 
system is achieved via the main running screen (Fig.18, see appendix 
Fig. 41). This takes the form of a large strip chart in the centre of the 
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screen, which mimics a patient monitor system and has a number of 
traces determined by the operational mode; a) calibration of Respitrace 
bands, the zero offset is then stored and applied to all subsequent 
readings, b) calibration of pressure readings against atmospheric 
pressure and a known pressure applied by a hand pump. The zero 
offset and gain adjustments are stored and applied to all subsequent 
pressure measurements of gastric and oesophageal pressure.  
Development of the new data acquisition program allowed real time 
graphic display of the signals and time synchronisation of the 
Respitrace unit and CO2SMO plus respiratory monitor. 
 
 
 
 
 
 
 
 
 
Fig.18: Data collection screen displaying signals from data acquisition 
system Poe = oesophageal pressure (blue), Pga = gastric pressure (green),  
RC = rib cage (red), AB = abdomen (white), Vt = tidal volume (lilac), flow (orange) 
PNT=pneumotachograph, Paw=airway opening pressure (yellow)
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2.8.7 Software for data analysis 
The program for data analysis was developed in collaboration with 
Cape Biotech in South Africa. Data was stored in Excel for importing at 
a later time to a graphic display of the signals (Fg.19).  
 
The data was filtered using a fourth order Butterworth filter. The cutoff 
frequency was stipulated above the filtered data results.  The filtering is 
therefore conducted with a cutoff frequency of 50Hz and 42Hz.  These 
were obtained by trial and error knowing that ambient and electrical 
noise averages around 50Hz. The rate chosen was found to provide the 
best (smoothest) results without skewing the data.  The higher the 
sampling rate the more sensitive the filter, the less smooth the curve 
and the more peaks and valleys are detected.  
 
Pressure time product (PTP) was calculated by integrating the area 
under the pressure curve. Diaphragmatic pressure time product (PTPdi) 
was the difference between oesophageal pressure time product 
(PTPoe) and gastric pressure time product (PTPga). Phase angle was 
calculated as the phase shift between the peaks of rib cage and 
abdominal waveforms. These parameters were calculated for each 
breath and then averaged over the selected period. Expiratory time was 
derived by calculating the time between peak and valley of the 
abdominal wave based on a sampling rate of 100Hz. Respiratory time 
76 
 
was derived by counting the number of peaks of the abdominal wave 
over the selected time period and calculated per minute. 
Breathing cycles valid for data analysis could be selected manually by 
entering start and end point of the data strip. Criteria for selection of 
breathing cycles were identifiable peak for RC and AB waves. Excluded 
from data analysis were artefacts and episodes of apnoea. 
 
 
 
Fig.19: Data analysis screen  
 
Showing filtered rib cage, abdominal, gastric pressure and oesophageal pressure 
signals. Peaks and valleys of all signals are marked. Blue=Poe and AB, red=Pga and 
RC, RC = ribcage, AB=abdomen, Pga=gastric pressure, Poe=oesophageal pressure, 
min=minimum, max=maximum 
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2.8.8  Safety and infection control 
The safety of the equipment was certified by the technical department 
of St Mary’s Hospital, London and Tygerberg Hospital, University of 
Stellenbosch, Cape Town, South Africa. The respiratory monitor was 
serviced by Respironics, Johannesburg, South Africa. 
The data acquisition unit was connected to a patient isolation 
transformer, which separated the equipment from the mains. 
The equipment and equipment trolley was disinfected before and after 
each use according to hospital guidelines. The Respitrace bands and 
flow sensors were used only once. The catheter pressure transducers 
were sterilized with Instrubac (Respiratory Care Africa Ltd - Benzyl 
Ammonia Chloride, Quaternary Compound) before and after every use.   
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2.8.9. Validation of equipment 
2.8.9.1  Validation of pressure measurements 
Validation of pressure measurements were obtained by applying a 
known pressure from -50 to 50 mmHg, in 10 mmHg steps, via a hand 
pump. Each pressure was applied for 10 seconds. The distal end of the 
catheter was inserted into a calibration tube. The proximal end was 
screwed tied around the catheter to avoid an air leak; the distal end was 
connected to a hand pump and water manometer (Fig.20). Pressure 
readings of hand pump, water manometer and equipment were 
recorded and compared with each other. The procedure was repeated 
for each catheter before initiation and after completion of the project. 
The water manometer was not available before initiation of the study 
and measurements were made exclusively via hand pump (please note 
that negative pressures could only be applied in the presence of a water 
manometer via pressure release valve). 
 
    Water manometer             
Valve                                                                       Catheter 
 
 
Water                                                           Calibration tube 
level 
                                            
                                         Tight seal           
                                                                           Pressure sensors    
                                                                                                                
 
Fig.20: Equipment set up for validation of pressure measurements 
 
Hand pump 
 
 
Data 
acquisition 
unit 
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Hand pump vs. gold standard water manometer: 
The result shown in Fig.21 demonstrates a linear relationship between 
pressure readings of the hand pump and gold standard water 
manometer with a correlation coefficient (R2) of 0.999 and 0 off set.  
Therefore the hand pump can be used to calibrate the catheters. 
 
 
 
 
 
 
   
 
 
 
Fig.21: Correlation of pressure measurement of hand pump and water 
manometer. Each dot represents mean pressure values over a 10 second period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
Catheters vs. hand pump and gold standard water manometer: 
Correlation of pressure readings of the hand pump, water manometer 
and catheters are illustrated in Table 4. The correlation coefficient (R2) 
was 0.999 with 0 off set prior to initiation of the project when pressures 
of 0 to 50 mmHg were applied. After completion of the project, 
pressures between -50 and 50 mmHg were applied; the correlation 
coefficient did not change significantly but the off set ranged from -14 to 
30. 
 
Table.4: Performance of catheters at beginning and end of the project 
Time of 
validation 
prior to project after completion of project  
Pressure 
range 
0-50 mmHg   0-50 mmHg -50 – 0 mmHg  
 R2 off 
set 
R2  off 
set 
R2 off  
set 
number of 
times used 
Catheter1                  
sensor  a 
sensor  b 
 
0.999 
0.999 
 
0 
0 
 
1 
1 
 
0 
10 
 
0.998 
0.998 
 
0 
0 
 
8 
Catheter 2                 
sensor  a 
sensor  b 
0.999 
0.999 
 
0 
0 
 
0.984 
0.974 
 
9 
30 
 
0.999 
0.999 
 
0 
0 
 
4 
Catheter 3                 
sensor  a                      
sensor  b 
0.999 
0.999 
 
0 
0 
 
1 
0.999 
 
-5 
-14 
 
0.999 
0.997 
 
0 
-9 
 
27 
Catheter 4                
sensor  a                       
sensor  b 
0.999 
0.999 
 
0 
0 
 
NA 
NA 
 
NA 
NA 
 
NA 
NA 
 
NA 
NA 
 
11 
a= oesophageal pressure sensor, b=gastric pressure sensor 
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2.8.9.2 Validation of Respitrace band 
A Respitrace band (15”) was placed “at snug fit” around a wooden block 
(Fig. 22) to compare the amount of stretch versus output. One half of 
the block was fixed onto a surface and the other half was manually 
moved along the surface in 0.5 cm steps and kept in position each time 
for 10 seconds. During this time the Respitrace band output was 
continuously recorded. The mean value of the recordings was 
calculated and plotted against the amount of stretch (cm). 
 
 
 
Stationary  
block 
 
 
 
 
 
 
 
 
 
         
    Tape cm              adjustable block    
 
Fig.22:  Adjustable wooden block  
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Fig. 23 illustrates a linear relationship (R2 = 1) between the stretch of 
the Respitrace band and output (arbitrary numbers). Therefore it can be 
concluded that the amplitude of the abdominal and rib cage wave is 
related to the abdominal and rib cage movements.  
 
 
 
 
 
 
 
 
 
 
 
Fig.23: Respitrace band output at different lengths 
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2.9 Procedures 
Efforts were made to handle the subjects according to the Newborn 
Individualized Developmental Care and Assessment Program, NIDCAP. 
A nest made of towels was built to comfort the subjects. 1-2 drops of 
sucrose were given orally if the subjects were unsettled. The subjects 
were measured in supine position and the mouth was kept closed with a 
soft elastic chin strap, which allowed voluntary movements by the 
subjects including yawning.  
 
Adjustment period between each pressure setting was circa 10 minutes 
or once the subjects were settled. Following a 10 minute adjustment 
period, breathing cycles were recorded for 5 minutes. During this time 
no interference with the subject was made unless clinically necessary. If 
the catheter dislodged or the Respitrace bands loosened the study data 
recordings were stopped and reinitiated when catheter and bands were 
again in place.  
 
According to unit guidelines FiO2 was adjusted to keep saturations 
between 85-90% for neonates < 1.5kg or a gestational age of < 32 
weeks, 88-92% for neonates > 32 weeks and 90-95% for neonates ≥ 36 
weeks of gestational age.  
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All subjects had a nasogastric tube in situ, which was part of their 
routine care. It was felt that the subjects were too small in size to have 
two catheters in situ at the same time. Therefore the nasogastric tube 
was removed during the measurements. All participants received either 
intravenous fluid or bolus feeds. Those receiving bolus feeds were 
studied in between feeds. 
 
The catheter was placed by visual inspection of the real time display of 
all signals. The catheter was inserted orally and both sensors were 
placed into the stomach. The catheter was then withdrawn until a 
negative deflection of the oesophageal pressure was seen. Throughout 
the breathing cycles the oesophageal pressure signal had a negative 
deflection and the gastric pressure signal a positive deflection of the 
pressure curve during inspiration and vice verse during expiration. The 
oesophageal pressure sensor was placed between lower oesophageal 
sphincter and the heart. An occlusion test was then performed. NCPAP 
was disconnected. A face mask pneumotachograph was applied and 
the subjects were breathing against an occluded airway for 3-5 breaths. 
During this time vital signs were continuously monitored.   
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2.10 Preliminary studies 
Preliminary studies were conducted between January 2009 at St Mary’s 
Hospital NHS Trust, London, UK and in June 2009 at Tygerberg 
Hospital, Cape Town, South Africa. 
 
Stage 1: Techniques including placing the Respitrace bands and 
placing the oesophageal gastric pressure transducer by volunteer 
(myself) experiments were learned. Recognition of artefacts, 
physiological phenomena (lower sphincter contractions, oesophageal 
contractions cardiac beats) and anatomical orientation was learned in 
special observatory sessions in the adult endoscopy unit at St Mary’s 
Hospital. 
 
Stage 2: Four subjects were recruited under supervision of experienced 
senior neonatologists at the neonatal intensive care unit at St Mary’s 
Hospital within a period of three months. During the period of study the 
neonatal unit changed the nCPAP protocol and half of the patients that 
would have received nCPAP received nSIPAP (nasal synchronised 
intermittent positive airway pressure). This reduced number of patients 
that would receive nCPAP and lead to the conclusion, that the study 
could not be successfully competed at the St Mary’s site within the 
proposed time frame.  
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Stage 3: Collaboration with a neonatal centre in Cape Town was 
initiated. This unit is a tertiary care unit but because of the imbalance 
between admitted numbers of babies and available resources, intensive 
care treatment cannot be offered to all patients. NCPAP is therefore 
very commonly applied and is very often the only chance for preterm 
babies to survive.  A pilot study of 16 subjects was conducted to test 
feasibility and equipment.  
 
The following technical problems became apparent: 
1. Break down of data acquisition unit due to electrical interference 
of ventilators, infusion pumps etc. 
2. Defect in cables caused by overseas transport 
3. Data overflow caused a decrease in sample rate  
 
Solutions to some of the problems were: 
1. Thicker, insulated cables to reduce electrical interference 
2. Replacement of defective cables 
3. Remodelling of software program for data collection via remote 
laptop (SSDC Ltd)  
 
Sixteen subjects were recruited within 2 weeks, the equipment was fully 
functional and techniques including placement of oesophageal gastric 
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catheter by the operator had improved. It was concluded that a larger 
study was feasible. 
 
 
2.11 Sample size 
The lack of published data did not allow for a sample size calculation 
but similar physiological studies (37;97) previously published, recruited 
up to 40 subjects. Keeping in mind the data might be of poor quality in 
some cases an extra 10 subjects were added. I therefore, opted for a 
sample size of 50 that was supported by statistician advice. Due to 
logistics it was decided to use a convenience sample. 
 
 
2.12 Randomisation sequence generation 
The pressure sequence of 2, 4, 6 and 8 cmH2O was determined by a 
computer generated simple randomisation code 
(http://www.randomization.com). 
The randomisation list was kept in the research file. The subjects were 
allocated by the investigator according to the sequence of 
randomisation codes on the list. 
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2.13 Blinding 
The investigator was not blinded but measurements were purely 
recorded by the data acquisition unit except for one parameter (FiO2), 
which was adjusted manually and read from a dial on the nCPAP 
device. All subjects were not aware of the interventions due to their age. 
Parents and staff were informed but did not interfere with monitoring 
equipment at any stage throughout the study.  
 
 
2.14 Reproducibility of data 
The data strip for PTPoe were split in half (a and b) by the investigator. 
Efforts were made to have an equal distribution of numbers of breathing 
cycles and lengths (seconds) of the data strips for each half. “Optimal” 
CPAP was determined as defined by the lowest PTPoe for each half of 
the data strip. Good reproducibility was achieved if the same “optimal” 
CPAP was identified in each half. The same procedure was repeated 
for PTPga and PTPdi. 
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2.15 Statistical methods 
The package R was used in all of the statistical calculations (R: 
Development Core Team 2009). R: A language and environment for 
statistical computing. R: Foundation for Statistical Computing, Vienna, 
Austria; ISBN 3-900051-07-0, URL http://www.R-project.org,  
 
Assumptions: 
Data characteristics and assumptions were investigated by the use of 
frequency distribution diagrams, scatter plots and linear regression 
models (see appendix Fig.37-38).  
 
Effect of randomisation code on PTPoe: 
The effect of the randomised pressure sequence on PTPoe was 
analysed via a linear mixed effects model fit by REML (=Random 
Effects Models of Longitudinal Data). Each nCPAP level 2, 4, 6 and 8 
was associated with one of the numbers 1, 2, 3 and 4 depending on the 
randomisation order. For example, if nCPAP level 8 was applied first 
then the PTPoe value at nCPAP 8 is indexed by the value 1. A new 
variable was created which indicated the randomisation order. PTPoe 
vs. nCPAP was analysed as independent variable and with 
randomisation order.  
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Relationship of two variables: 
To investigate the relationship between nCPAP and selected variables 
a regression coefficient (gradient b) was calculated using the regression 
equation y = a + bx.  
 
Percentage change of PTP between different nCPAP ranges: 
The changes in work of breathing from 2-4, 4-6 and 6-8 cmH2O were 
calculated by using the result of the mixed model regression of PTP on 
nCPAP.   
 
Correlation of two variables: 
To investigate the strength of the relationship between two variables a 
correlation coefficient was obtained between PTP values and selected 
parameters at all nCPAP level. The same method was used to 
demonstrate reproducibility of data and the effect of adjustment time on 
PTPoe. 
 
Predictors of PTP’s: 
Multiple regression analysis was used to fit prediction models for each 
PTP. The predictive effectiveness of a linear combination of those 
parameters can be assessed by multiple regressions of the dependent 
variables (PTP’s) on the predictors. This was done for various 
combinations of the predictors and dependent variables. The same 
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statistical methods were used to determine the relationship between 
demographic and clinical characteristics of the subjects and PTPoe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92 
 
3 Results 
 
Participants were recruited during August 2008 and between January 
and March 2009. 
 
3.1 Participant flow 
A convenience sample of 56 subjects was recruited. In 11 subjects 
measurements could not be completed and 8 subjects were excluded 
from data analysis because of poor quality of the data. A total of 37 
subjects and 26 221 breathing cycles were analysed (Fig.24). 
 
 
 
 
  
 
 
 
 
 
 
 
Fig.24: Participant flow chart 
56 subjects 
45 subjects 
37 subjects 
Excluded due to: 
Prolonged apnea (2) 
Desaturation (1)  
Unsettled (6)  
Failure to position catheter (1) 
Equipment failure due to environmental electrical 
 interference (1) 
Excluded from data analysis due to: 
 Poor quality data (8) 
Analysed signals for n subjects: 
Poe   32 
Pga   33 
RC   34  
AB   37 
 
 
 
 
 Total number of analysed breathing cycles: 
N = 26 221 
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Median GA in weeks  30±4.9 
Median BW in g   1234±443 
CA at study in hours:   
≤24                       24(64.9%) 
24-48     5(13.5%) 
>48     8(21.6%) 
Male     22(59.5) 
Mixed race / black       19(51%) / 18(49%) 
 
Baseline FiO2    ≤0.35 
Antenatal steroids    24(64.9%) 
Caesarean section   15(42.9%) 
In and out surfactant   14(37.8%) 
PDA insignificant    2(5%) 
PDA significant    8(22%) 
HIV exposed    5(13.5%) 
VDRL positive   4(10.8%) 
Previously mechanically  1(2.7%) 
ventilated in days    
 
3.2 Baseline data 
After 37 subjects were included; median gestational age 30±4.9 weeks, 
median birth weight 1234±443g, chronological age ≤ 24hours 24 
(64.9%) and baseline FiO2 ≤ 0.35 (Table 5, 6). 
 
 
Table 5: Demographic data  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Clinical characteristics 
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3.3 Effect of randomisation code on PTP 
The relationship of PTPoe versus nCPAP was investigated at different 
pressure sequences (i.e. 2, 6, 8, 4 or 8, 2, 6, 4 etc.). The results of the 
analysis demonstrated that there was no relationship between 
randomisation order and PTPoe (see appendix Table 18) 
 
 
3.4 Effect of adjustment period on PTP 
The adjustment time varied from 10 to 27 minutes with a mean of 12 
minutes. The scatter plot (see appendix Fig. 39) illustrates that in most 
of the subjects the adjustment period was 10 to 15 mins at all nCPAP 
levels. The correlation coefficients between mean PTPoe and 
adjustment period at nCPAP of 2, 4, 6 and 8 cmH2O are respectively -
0.001, -0.056, -0.146 and 0.312. None of them is significant. (A 
correlation coefficient greater in absolute value than 0.331, implies 
statistical significance at a p value of 0.05). Therefore adjustment time 
did not have an influence on PTPoe in this study. 
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3.5 Reproducibility of “optimal” CPAP 
Optimal nCPAP (OCPAP) was defined as the pressure level with the 
lowest PTPoe values.  OCPAP of the first half (a) of the data strip was 
plotted against OCPAP values of the second half (b) (Fig.25). There are 
6 outliers that influence the calculation of the correlation coefficient (R2) 
significantly. Nevertheless, the scatter plot shows a satisfying 
correlation between data from strip a and strip b (R2= 0.575, p < 0.001). 
The same method was used for PTPga (Fig.26) and PTPdi (Fig.27). 
The relationship between OCPAP (a) PTPdi versus OCPAP (b) PTPdi 
was also satisfying despite 4 outliers (R2= 0.592, p < 0.001). There was 
a weaker correlation (R2= 0.447, p = 0.008) between OCPAP (a) PTPga 
versus OCPAP (b) PTPga with 12 outliers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.25:  Reproducibility of PTPoe 
OCPAP = optimal CPAP, PTPoe = oesophageal pressure time product   a = first half 
of data strip, b = second half of data strip, (R2= 0.575, p < 0.001) 
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 Fig.26: Reproducibility of PTPdi 
 OCPAP = optimal CPAP, PTPdi = diaphragmatic pressure time product, a = first half 
of data strip, b = second half of   data strip, (R2= 0.592, p < 0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.27: Reproducibility of PTPga 
OCPAP = optimal CPAP, PTPga = gastric pressure time product, a = first half of data 
strip, b = second half of data strip, (R2= 0.447, p = 0.008) 
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3.6 Nominal versus received nCPAP level 
There was a good correlation between nominal (set) and received 
(measured) CPAP (Fig.28 and Table 7). 
 
Table 7: Nominal versus received CPAP 
 
 
 
 
 
 
 
 
 
 
 
SD=standard deviation, COV=coefficient of variance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.28: Nominal CPAP versus received CPAP 
 
Set CPAP cmH20 2 4 6 8 
Average measured CPAP 
mH20 
1.87 3.79 5.73 7.59 
SD cmH2O 0.25 0.29 0.23 0.42 
COV% (SD/mean) 13.25 7.68 4.02 5.59 
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3.7 Relationship between selected variables and nCPAP 
PTPoe, PTPga and PTPdi decreased (negative slope) in reverse 
proportion to the received CPAP levels. The largest negative slope was 
seen for PTPoe. A significant downward trend was also demonstrated 
for parameters derived by RIP, including abdominal excursion (∆AB) 
and respiratory rate (RR) whereas an upward trend (increase) in 
expiratory time (Te) was seen at increased nCPAP levels. 
Thoracoabdominal asynchrony (PA = phase angle) decreased but failed 
to reach statistical significance. Clinical parameters including oxygen 
requirements (FiO2) decreased with increasing nCPAP levels, whereas 
no changes were seen for heart rate (HR). These results suggest that 
all parameters except PA and HR change (either decrease or increase) 
at different levels of nCPAP (Table 8). 
Table 9 illustrates the mean values and standard deviations for all 
selected variables at different nCPAP levels (see appendix Fig. 40). 
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Table 8: Trends of selected variables at received CPAP  
 
*| Z slope | >1.96 implies statistical significance at level p<0.05 
 
 
 
 
Variable 
(mean ) 
intercept standard 
error 
slope standard 
error 
z slope 
PTPoe 388.81 24.64 -13.62 2.40 -5.67* 
PTPga 135.99 8.91 -3.432 1.388 -2.47* 
PTPdi 260.24 23.42 -10.62 2.52 -4.21* 
PA 92.66 10.66 -3.080 1.908 -1.61 
∆AB 44.49 2.94 -1.009 0.312 -3.23* 
RR 117.35 3.43 -1.914 0.356 -5.38* 
Te 0.3343 0.0174 0.0101 0.0019 5.31* 
HR 148.81 3.09 0.0183 0.4061 0.05 
FiO2 25.61 1.24 -0.3751 0.1509 -2.49* 
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Table 9: Changes of selected variables at nominal CPAP 
NCPAP 2 4 6 8 
 n mean ± SD n mean ± SD n mean ± SD n mean ± SD ) 
PTPoe 
cmH2O / sec 
36 360.2 ± 127.8 36 340.1 ± 157.2 36 315.8 ± 148.5 36 271.9 ± 129.6 
PTPdi 
cmH2O / sec 
36 234.0  ± 124.9 36 224.4 ± 145.7 36 212.2 ± 139.3 36 161.8 ± 118.5 
PTPga 
cmH2O / sec 
34 128.4 ± 37.8 36 122.1 ± 52.7 36 111.4 ± 43.4 35 111.6 ± 47.9 
PA○ 33 86.8 ± 50.7 34 81.6 ± 54.0 34 74.0 ± 57.2 31 70.2 ± 67.6 
∆AB 37 43.70 ± 18.6 37 39.7 ± 16.8 37 37.2 ± 14.7 37 38.4 ± 17.0 
Te/sec 37 0.35 ± 0.09 37 0.37 ± 0.09 37 0.41 ± 0.14 37 0.43 ± 0.15 
RR / min 37 114.5 ± 19.8 37 108.8 ± 19.3 37 105.9 ± 22.5 37 101.9 ± 20.3 
HR / min 37 148.5 ± 19.2 37 148.9 ± 16.5 37 150.0 ± 19.2 37 147.7 ± 18.2 
FiO2  37 0.25 ± 0.7 37 0.23 ± 0.5 36 0.23 ± 0.5 33 0.23 ± 0.5 
N = number of subjects, PTPoe = oesophageal pressure time product, PTPdi = diaphragmatic pressure time product, PTPga, = gastric pressure time product, PA = phase angle,  
∆AB = abdominal excursion, Te = expiratory time, RR = respiratory rate, HR = heart rate, FiO2 = fraction of inspired oxygen
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3.8 Relationship between PTP values and listed variables 
Table 10 illustrates a summary of correlation coefficients between 
PTPoe and listed variables at each nCPAP level. A correlation 
coefficient greater in absolute value than 0.331, implies statistical 
significance at p<0.05.  Best values are seen for the relationship 
between PA, ∆AB and RR with PTPoe. There was a poor correlation 
between PTPga, PTPdi and listed variables (Table 11 and 12). 
 
Table 10: Correlation coefficient of various variables with PTPoe at 
nominal CPAP levels 
                  
 
*Correlation coefficient (R2) > |0.331| implies statistical significance at p<0.05  
PA=phase angle, ∆AB=abdominal excursion, RR=respiratory rate, Te=expiratory rate, 
HR=heart rate, FiO2=fraction of inspired oxygen 
 
 
 
 
 
 
 
CPAP 
cmH2O 
2 4 6 8 
PA○ 0.391* 0.310 0.348* 0.373* 
∆AB 0.336* 0.553* 0.367* 0.308 
RR /min 0.355* 0.213 0.373* 0.620* 
Te / sec -0.311 -0.076 -0.263 -0.475* 
HR /min -0.120 0.111 0.071 -0.124 
FiO2 0.214 0.455* 0.335* 0.330 
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Table 11: Correlation coefficient of various variables with PTPdi at 
nominal CPAP levels: 
 
CPAP 
cmH2O 
2 4 6 8 
PA○ 0.340* 0.256 0.209 0.266 
∆AB 0.205 0.460* 0.256 0.227 
RR /min 0.419* 0.161 0.366* 0.566* 
Te / sec -0.397* -0.036 -0.270 -0.436* 
HR /min -0.117 0.117 0.091 -0.160 
FiO2 0.174 0.385* 0.278 0.165 
*Correlation coefficient (R2) > |0.331| implies statistical significants at p<0.05 
PA=phase angle, ∆AB=abdominal excursion, RR=respiratory rate, Te=expiratory rate, 
HR=heart rate, FiO2=fraction of inspired oxygen 
 
 
 
Table 12: Correlations coefficient of various variables with PTPga at 
nominal CPAP levels: 
 
*Correlation coefficient (R2) > |0.331| implies statistical significance at p<0.05 
PA=phase angle, ∆AB=abdominal excursion, RR=respiratory rate, Te=expiratory rate, 
HR=heart rate, FiO2=fraction of inspired oxygen 
 
 
CPAP 
cmH2O 
2 4 6 8 
PA○ 0.018 0.204 0.391* 0.145 
∆AB -0.062 0.294 0.265 0.013 
RR /min 0.015 0.172 -0.042 0.245 
Te / sec -0.116 -0.141 0.040 -0.204 
HR /min -0.100 -0.009 -0.068 -0.026 
FiO2 0.226 0.225 0.159 0.403* 
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3.9 Distribution of “optimal” CPAP levels 
Optimal CPAP was defined as the CPAP level with the lowest PTP 
values. Fig.29 illustrates the distribution of optimal CPAP defined as the 
pressure with the lowest PTPoe. The majority of subjects had lowest 
values between 6-8 cmH2O. Similar distributions were found for optimal 
CPAP defined as the pressure with the lowest PTPdi (Table 13). 
 
 
 
 
 
 
 
 
 
 
 
     cmH2O 
Fig. 29: Distribution of CPAP levels with lowest oesophageal pressure 
time product (PTPoe) 
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Table 13: Number of subjects at “optimal “CPAP 
PTPoe=oesophageal pressure time product, PTPdi=diaphragmatic pressure time 
product, PTPga=gastric pressure time product, optimal CPAP defined as the lowest 
pressure time product 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPAP range 
cmH2O  
2 – 4 4 - 6 6 - 8 
PTPoe 8 6 18 
PTPdi  8 6 18 
PTPga  11 9 13 
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3.10 Percentage changes in PTP  between nCPAP levels 
The percentage decrease in, PTP from 2 to 4, 4 to 6 and 6 to 8 cmH2O 
was calculated using the results of the mixed model regression of 
PTP`s on nCPAP (Table 14).  
 
Table 14: Percentage change in PTP`s at different nCPAP levels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PTPoe=oesophageal pressure time product, PTPdi=diaphragmatic pressure time 
product, PTPga=gastric pressure time product 
 
 
 
 
3.11 Predictors of PTP 
Respiratory parameters derived by respiratory inductance 
plethysmography correlated best with PTPoe. Using multiple 
regression analysis, prediction models were formulated that took into 
consideration selected variables, demographic and clinical data. The 
best fitted model for PTP’s consisted of parameters including, 
respiratory rate (RR), abdominal excursion (∆AB), phase angle (PA), 
nCPAP level and demographic data including gestational age and birth 
CPAP cmH2O 2 → 4 4 → 6 6 → 8 
Mean PTPoe decrease % 7.5 8.2 8.9 
Mean PTPdi decrease % 8.9 9.8 10.8 
Mean PTPga decrease % 5.3 5.6 5.9 
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weight (Table 15). Observed values of mean PTPoe were plotted 
against predicted values for all nCPAP levels. This model accounted 
for 65.8% (R=0.658) of the variance of PTPoe of which most values lie 
within 1 standard deviation (Fig.30).  The same model accounted for 
54.8% (R=0.54) and 41.6% (R=0.41) of the variance of PTPdi and 
PTPga. In comparison RR alone explained only 36.7% (R=0.367), PA 
0.7% (R= 0.007) and ∆AB 45.5% (R= 0.455) of the variance of PTPoe 
(Fig.31-33).  
 
Table 15: Best fitted model for PTPoe  
∆AB=abdominal excursion, RR=respiratory rate, PA=phase angle, GA=gestational 
age, BW=birth weight, recCPAP=received, S.E. =standard error 
 Value S.E. DF t-
value 
p-
value 
R Residual  
S.E. 
Intercept 32.98 101.50 87 0.32 0.746  
 
 
 
0.658 
 
 
 
 
110 
recCPAP -7.27 2.52 87 -2.88 0.005 
∆AB 3.36 0.70 87 4.80 0.000 
RR 1.82 0.56 87 3.27 0.002 
PA -0.48 0.14 87 -3.25 0.002 
GA -89.37 34.62 30 -2.58 0.015 
BW 75.98 39.49 30 1.92 0.064 
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PTPoe  
cmH2O /sec 
 
 
 
 
 
                                                         
 
 
 
 
 
                                                   
 
 
                                                      Best fitted model 
 
Fig. 30: Best fitted model for PTPoe 
                                                                 
 
 
PTPoe 
cmH2O / sec 
 
 
 
 
 
 
 
 
                                                Fitted model ∆AB + nCPAP 
Fig. 31:  Fitted model ∆AB + nCPAP vs. PTPoe 
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PTPoe  
cmH2O/sec 
 
 
 
 
 
 
 
 
                                    Fitted model phase angle +nCPAP 
Fig. 32: Fitted model phase angle + nCPAP vs. PTPoe 
 
PTPoe 
cmH2O/sec 
 
 
 
 
 
 
 
 
                                         Fitted model respiratory rate + nCPAP 
Fig. 33: Fitted model respiratory rate + nCPAP vs. PTPoe 
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The same model was created for PTPdi, which predicted 54.8% of the 
variance of PTPdi at all nCPAP levels (Fig.34 and Table 16).  
 
Table 16: Best fitted model for PTPdi  
 
∆AB=abdominal excursion, RR=respiratory rate, PA=phase angle, GA=gestational 
age, BW=birth weight, recCPAP=received CPAP 
 
 
 
 
 
 
 
 
 
 Value s.e. DF t-
value 
p-
value 
R Residual  
s.e. 
Intercept 9.37 104.91 87 0.09 0.929  
 
 
 
0.548 
 
 
 
 
113 
recCPAP -6.21 2.66 87 -2.34 0.022 
∆AB 1.81 0.73 87 2.46 0.016 
RR 1.63 0.58 87 2.81 0.006 
PA -0.56 0.16 87 -3.61 0.000 
GA -89.91 35.27 30 -2.55 0.016 
BW 73.31 40.22 30 1.82 0.078 
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PTPdi 
cmH2O/sec 
 
 
 
 
 
 
 
 
 
                                                                Fitted model 
     
Fig.34: Fitted model vs. PTPdi 
The model, consisting of respiratory rate, phase angle, abdominal excursion, 
gestational age and birth weight, predicts 54.8% (R=0.54) of the variance of PTPdi at 
all nCPAP levels, dashed line=one standard deviation, line=regression line. 
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In contrast to PTPoe and PTPdi the best fitted model for PTPga 
consists only of one variable, ∆AB. This variable predicts 41.6% of the 
variance of PTPga (Fig.35 Table 17) 
 
Table 17: Best fitted model for PTPga  
∆AB=abdominal excursion, recCPAP=received CPAP  
 
 
PTPga 
cmH2O/sec 
 
 
 
 
 
 
 
                                                                Fitted model 
Fig.35: Fitted model vs. PTPga  
The model, consisting of abdominal excursion, predicts 41.6% (R=0.41) of the 
variance of PTPga at all nCPAP levels, dashed line=one standard deviation, 
line=regression line
 Value s.e. DF t-value p-value R Residual 
s.e. 
Intercept 71.65 15.37 86 4.66   0.000  
 
0.416 
 
 
42 
recCPAP 2.37 1.10 86 2.16   0.034 
∆AB 1.48 0.28 86 5.23   0.000 
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3.12 Relationship between PTP and  
demographic / clinical   characteristics  
A mixed model analysis demonstrates the relationship between 
PTP’s and covariates including birth weight, GA, CA, ethnic group, 
gender, HIV and VDRL status, use of surfactant and antenatal 
steroids and presence of a PDA. The data suggests no relationship 
between PTP and subject’s characteristics (see appendix Table 
19), which might be due to the small sample size and uneven 
frequency distribution. Nevertheless chronological age seemed to 
have a significant effect on PTPga (p = 0.017).  PTPga is higher for 
subjects that are more than 48 hours of age than for subjects that 
are less than 48 hour of age (Fig.36).   
 
 
 
 
 
 
 
 
 
 
 
 
                       Fig.36: PTPga at different chronological age 
                       Green = < 24 hours, red = 24-48 hours, blue = > 48 hours 
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3.13 Adverse events 
Out of 52 subjects, one suspected pneumothorax was reported 12 
hours after the study. The subject experienced a brief increase in 
respiratory distress with no change in FiO2, HR or BP. The chest X-Ray 
did not show a pneumothorax.  The patient did not require any other 
intervention.  
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4 Discussion 
 
To my knowledge this is the first study measuring pressure time 
product, as an index of respiratory muscle work load of the ribcage 
muscles, the diaphragm and abdominal muscles at different levels of 
nCPAP in neonates and identifying noninvasively determined predictors 
of the respiratory muscle work load.  
 
4.1 Relationship between selected variables and nCPAP levels 
The finding that PTP decreases in reverse order to the level of CPAP 
pressure suggests that increasing CPAP level is associated with a 
reduction in work of breathing.  The data therefore suggest that nCPAP 
unloads respiratory muscles (of the rib cage, the diaphragm and the 
abdominal muscles) in reverse proportion to the pressure level. This 
might be due to the fact that positive pressure assists inflation of the 
lung, improving compliance and thereby reducing the work of breathing. 
It is unclear what might have happened if the pressure levels would 
have been increased further. My findings are in accordance with other 
studies, which reported a decrease in respiratory muscle work load after 
the application of nCPAP in infants with upper airway obstruction (36) 
and bronchiolitis (87). A decrease of respiratory muscled work load by 
50 % was reported.  
Pressure time product 
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It has been suggested that real time measurements of work of breathing 
can be used to optimise mechanical ventilation (105). However, there 
are no reference values available for work of breathing in neonates 
presumably due to the technical challenges in doing such 
measurements. However, calculations of percentage changes in PTP at 
different ventilator settings could be used to optimize ventilation settings 
for the individual patient.  
 
Breathing pattern as derived by RIP 
This study demonstrated a significant decrease in abdominal excursion 
and an increase in expiratory time, with higher nCPAP level. Phase 
angle decreased (as expected) with increased nCPAP levels but 
(surprisingly) did not reach statistical significance.  
a. Expiratory time 
My results are in agreement with current literature (37;106). 
Prolongation of expiratory time could have been an effect of increased 
lung expansion due to increased nCPAP level.  
b. Phase angle 
Previous studies reported a significant decrease in phase angle (degree 
of thoraco-abdominal asynchrony) between 0 to 6 and 0 to 8 cmH2O 
(37;66;69). In my study PA decreased but the magnitude of change did 
not reach statistical significance. A decrease in phase angle might be 
expected due to the fact that nCPAP improves thoraco-abdominal 
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synchrony by stabilising the rib cage and therefore preventing inward 
motion of the rib cage. Reduction in diaphragmatic work load, and 
therefore it’s pulling force onto the lower ribs, may also be affected by 
application of nCPAP. 
c. Abdominal excursion 
Abdominal excursion in neonates at different levels of nCPAP has not 
been studied before. It is thought that the changes in abdominal 
excursion depend largely on the diaphragmatic movements (11). In my 
study abdominal excursion decreased in reverse proportion to the 
applied nCPAP level. It is reasonable to conclude that the 
diaphragmatic excursion decreased with increased nCPAP levels. 
 
It was demonstrated that respiratory rate significantly decreased with 
increased nCPAP levels which is in agreement with the other studies 
(37;69). Furthermore it was demonstrated that FiO2 decreased in 
reverse proportion to nCPAP levels, which might be due to improved 
oxygenation due to reduced atelectasis and improved alveolar 
recruitment or reduced intrapulmonary shunting (better matching of 
ventilation and perfusion). There was no change in heart rate, which is 
in agreement with the literature.  
Other clinical parameters 
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4.2 Relationship between PTP values and variables 
Out of all PTP values, selected parameters (HR, RR, Te, PA, ∆AB, 
FiO2) correlated the best with PTPoe. This might be due to the fact that 
the changes of PTPoe at different nCPAP levels were more 
pronounced.  Additionally the selected parameters might have been 
more representative of the work load of the rib cage muscles and 
diaphragm (PTPoe and PTPdi) than of abdominal muscle work load 
(PTPga). 
 
PA, ∆AB and RR correlated the best with PTPoe at 3 out of 4 nCPAP 
levels. The data suggests that thoraco abdominal asynchrony, 
respiratory rate and abdominal excursion correlate with respiratory 
muscle workload of the rib cage and diaphragm as measured by 
PTPoe.  This is due to the fact that the contraction of the diaphragm 
contributes to the distortion of the rib cage leading to an increase in 
phase angle and displaces the abdominal content downward and 
outward during inspiration, which will then lead to a change in 
abdominal excursion. Furthermore the diaphragm is the major 
inspiratory muscle and therefore closely related to respiratory time.  
Te and FiO2 correlated poorly with PTPoe. This suggests that those 
parameters do not correlate well with respiratory muscle work load and 
that the changes in Te at different levels of nCPAP are possibly due to 
stimulation of pulmonary stretch receptors during lung inflation. A 
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decrease in FiO2 was probably more likely to be due to reduced 
atelectasis other then respiratory muscle work load.  
 
 
4.3. “Optimal” CPAP 
To my knowledge, this is the first piece of work to demonstrate that 
nCPAP can be titrated against quantitative measures of respiratory 
muscle work load in neonates in order to optimise nCPAP therapy.  
 
The data suggests that “optimal” CPAP occurred for most subjects at 
higher nCPAP levels between 6-8 cmH2O which is in agreement with 
current literature (37;69;70). However this is in contrast to common 
clinical practise, as clinicians usually set the pressure level between 4-6 
cmH2O.  
 
Several factors though have limited investigations in regards to 
optimising nCPAP therapy. Technology to measure lung mechanics in 
patients receiving non-invasive respiratory support is limited and not 
available for clinical use.  
 
Furthermore there are concerns that the administration of higher 
nCPAP levels increase the risk of pneumothoraxes and decrease 
venous return and cardiac output. Although a recent study did not 
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confirm these (73)  concerns amongst clinicians in regard to cardiac 
decompensation at higher levels of nCPAP remain. 
 
  
4.4 Predictors of pressure time products 
Several models were fitted to investigate which parameters or 
combination of parameters best predicted the pressure time products. 
The best prediction model was fitted for PTPoe. I demonstrated that 
respiratory rate, phase angle and abdominal excursion alone are poor 
predictors of PTPoe.  
 
Banner et al. (96) investigated adults with acute respiratory failure 
receiving mechanical ventilation at different pressure settings. Work of 
breathing (WOB) was measured via an oesophageal balloon catheter 
and calculated from the Campbell diagram (area within the pressure 
volume loop). Respiratory rate accounted for only 22 % of work of 
breathing and breathing pattern score (respiratory rate, tidal volume, 
sternocleidomastoid muscle activity, substernal retraction and 
abdominal paradox) predicted 43% of the variance of WOB. It was 
postulated that respiratory rate and subjective assessment of 
respiratory muscle activity are inaccurate variables from which to infer 
the respiratory muscle work load. By using multiple regression analysis 
the authors formulated a prediction model consisting of breathing 
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pattern score, Ti/Ttot, and Vt predicting 50% of the variance of WOB, 
which was felt to be non satisfactory.  
 
Few years later Banner et al. (105) developed an artificial neural 
network. It consisted of five selected variables derived by airway 
pressure/flow signals and predicted 99 % of the variance of the 
respiratory muscle work load as calculated by the power of breathing. 
No significant relationships were found in comparison to power of 
breathing to respiratory rate, tidal volume, PaO2, PaCO2, PaO2/FiO2, 
Ti/Ttot, compliance and resistance of the respiratory system. It was 
reported that respiratory rate and tidal volume did not correlate with the 
power of breathing all the time but are still valuable parameters to 
assess pulmonary function and ventilator therapy. The index of rapid 
shallow breathing (respiratory rate/ tidal volume) was also found to be a 
poor indicator of the respiratory muscle work load in mechanically 
ventilated adults.  
This questions current strategies to titrate respiratory support, such as 
CPAP, against clinical status with regard to respiratory rate, indices of 
oxygenation or subjective assessment of respiratory distress. 
In infants with bronchiolitis though, respiratory distress was assessed 
by the modified Wood’s clinical asthma score (cyanosis, inspiratory 
breath sound, accessory muscle use, expiratory wheezing and cerebral 
function).  A significant correlations was found between modified 
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Wood’s clinical asthma score and, respectively, Poe swings (r = 0.56, p 
= 0.004), PTPoe inspiratory/breath (r = 0.60, p = 0.001) and PTPoe 
inspiratory/min (r = 0.61, p = 0.001). After nCPAP, a significant 
correlation between the decrease in Pes swings and accessory 
muscles’ use score (r = 0.8, P = 0.001), and the reduction in Poe 
swings and wheezing score (r = 0.70, P = 0.02) was also detected, but 
there was no correlation between the Wood’s asthma score and 
PTPoe/breath and PTPoe/min (87) 
 
Our prediction model consisting of respiratory rate, abdominal 
excursion, phase angle, gestational age and birth weight accounted for 
65.8 % of the variance of PTPoe.  Parameters including expiratory time, 
FiO2, heart rate, persistent ductus arteriosus, use of surfactant, 
antenatal steroids, chronological age, ethnic origin or gender were 
found to be poor predictors of PTP. This might have been due to a 
small sample size or the fact that recruited patients were in the less 
severe category of respiratory distress.   
 
To our knowledge quantitative predictors of respiratory muscle work 
load have so far not been determined in neonates during nCPAP 
therapy. Our prediction model is the first of its kind and could represent 
the first step to novel strategies in nCPAP therapy.  
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Randomised clinical trials investigating the benefits of such 
measurements of respiratory muscle work load in patients on ventilatory 
support are lacking but one study reported that patients weaned faster 
from mechanical ventilation by approximate 50% when weaned 
according to objective measures of breathing pattern (107).  
  
 
4.5 Subgroup analysis 
Additionally, subgroup analysis of my data suggested that PTPga was 
significantly higher in subjects older than 48 hours of age compared to 
subjects younger than 48 hours of age at all nCPAP levels. These 
findings might suggest an increased work load of the abdominal muscle 
due to a more obstructive component of the lung disease. An increase 
in PTPga might also have been caused by grunting due to suboptimal 
nCPAP treatment. Furthermore, subjects older than 48 hours of age 
usually would have been started on enteral feeding, which might have 
led to a general increase in gastric pressure. Although this finding is 
very interesting, explanations in regards to the mechanisms involved 
remain speculative. 
 
In summary, from the results of my work I would recommend titration of 
nCPAP according to patient’s ventilation needs. I do not suggest 
ignoring clinical judgment, rather using a combination of objective 
 123 
 
measurements of lung mechanics and clinical observation, to optimise 
nCPAP therapy.  Furthermore energy expenditure in the newborn is 
related to a number of factors including age, weight, treatment and 
disease. For the respiratory system it is thought that the force 
generated by the respiratory muscle is equivalent to the metabolic cost 
of breathing. Optimising work of breathing might decrease energy 
expenditure and improve growth and morbidity.  
 
 
4.6 Limitations of the study 
Environment: 
The study took place in busy neonatal intensive care and special care 
units. This is an uncontrolled environment, which has an affect on 
measured lung mechanics. Noise levels, staff activity, and necessary 
interventions might have disturbed the sleep pattern of the subjects, 
provoked sudden movements or crying. This might have led to sleep 
deprivation, which has been shown to increase respiratory events 
including apnoea, hypopnoea, periodic breathing and obstructive events 
(108). Ways to avoid those effects are to study the subjects in a 
laboratory, but not feasible as the subjects require intensive medical 
attention.  
 
 
 124 
 
Measurements of work of breathing are also altered by the sleep state 
of the neonate. Intercostal muscles are inhibited during REM sleep, 
which affects the degree of rib cage distortion and diaphragmatic 
activity. The constant change of noise levels on the unit caused a 
significant disruption to the natural sleep pattern of the neonate, which 
means that throughout the measurements the behavioural state might 
have changed several times affecting lung mechanics.  This makes it 
very difficult to assess behavioural state according to Prechtl criteria 
(assessment of eye movements, muscle tone etc.) along with 
simultaneous measurements of lung mechanics. Electromyogram would 
have been an objective and accurate method to assess the sleep state 
but it would have been too disturbing to the subjects. Therefore the 
complexity of the study did not allow for assessment of their behavioural 
state.       
Recording of sleeps state; 
 
Participants 
Subjects were recruited according to eligibility criteria and availability of 
the investigator. Only one subject at the time could be studied due to 
equipment limitations and staff. If more than one subject was eligible at 
the same time, the investigator might have chosen to recruit the more 
clinically stable subject first. The fact that only one subject could be 
studied at any given time precluded the investigator from studying many 
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subjects during the acute phase of their disease. The time window to 
study preterm babies on nCPAP is very short as most patients do not 
require nCPAP treatment for a long time. Patients who are severely ill, 
extreme preterm or on long term nCPAP might have been too unstable 
to be recruited. Therefore the sample population might not have been a 
true representation of the population in question. This does not 
minimise the results of the study. It is more likely that more pronounced 
changes of the parameter especially of the pressure time product would 
have been observed in more severely ill subjects.  
 
Procedures: 
The study was designed according to ERS task force to the best of the 
investigators’ ability.  It is necessary to standardise lung function testing 
in order to be able to compare the results of different studies and 
minimise the effect of any intervention on lung mechanics. Therefore 
the subjects were studied in supine position; head in neutral position 
and with their mouth closed. This does not reflect real life and in clinical 
practice the patients would change ever so often from prone to supine 
position with their head tilted and mouth open or closed. This does 
influence the lung mechanics for example a tilting of the head causes 
upper airway obstruction, an open mouth can lead to air leak and a 
reduced CPAP reaching the lungs, which can also be a protective 
mechanism and avoid lung hyperinflation. It has also been shown that 
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the prone position stabilises the chest wall and improves thoraco 
abdominal synchrony throughout the breathing cycle (109). On the 
other hand Rehan et al. (71)demonstrated in healthy term infants that in 
prone position the diaphragm is thicker and shorter. This impairs 
diaphragm strength and the infant’s capacity to respond to respiratory 
loads. It has also been shown that oesophageal pressure 
measurements are influenced by gravity, weight of the thoracic content 
and by posture (88). Therefore efforts were made to study all subjects 
in the same position.  
 
The standard technique (occlusion test) to place the catheter into the 
last third of the oesophagus proved to be quiet difficult in preterm 
infants. Placement of the mask, which was connected to a neonatal flow 
sensor, caused apnoeic episodes in some subjects, mainly preterm 
<1.5kg babies. Also, the recommended occlusion ratio of 1±0.05 was 
difficult to achieve. Reasons for not achieving a satisfying ratio include 
conditions that do not allow pressure to equilibrate through out the 
respiratory system during the occlusion test. This is often the case in 
lungs that are unequally ventilated; as in lung diseases or stiff lungs due 
to surfactant deficiency. Air leaks around the face mask and insufficient 
induction of the Hering Breuer reflex can also lead to an unsatisfactory 
occlusion test. The pressure sensor should be place between the lower 
oesophageal sphincter and the heart to avoid distortion of the pressure 
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signal by cardiac and sphincter artefacts. In preterm infants this space 
is very small and constant oesophageal contractions or diaphragmatic 
movements will displace the catheter upwards or downwards. A real 
time display of the data allowed constant observation of the pressure 
signal and the position of the catheter could be adjusted if necessary. It 
is crucial to perform an occlusion test if the oesophageal pressure is 
incorporated in calculations of lung compliance because of the pressure 
gradient in the thorax. In this study lung compliance was not calculated, 
the catheter was fixed properly and kept in the same position and every 
patient was its own control. Therefore a perfect occlusion test was not 
warranted. In addition disconnecting the subject for a longer period to 
achieve a perfect occlusion test might lead to atelectasis and 
deterioration in lung mechanics. In summary unsatisfactory occlusion 
ratios were accepted and the position of the catheter was checked by 
visual inspection of the pressure signal on the laptop screen.  
 
The generation of respiratory muscle force depends not only on the 
respiratory load imposed onto the respiratory system by disease but 
also its maturity.  Immaturity of the respiratory centre, neuronal 
pathways or the muscle it self, alters the generation of force measured 
by the pressure time product. An increase of the respiratory load due to 
insufficient CPAP might have caused muscle fatigue and therefore a 
Lung mechanics: 
 128 
 
decrease in PTP. The CPAP level would then have been labelled 
falsely as “optimal” CPAP as defined by the pressure level with the 
lowest PTP. To reduce the possibility of muscle fatigue, the duration of 
the study was kept short and handling of the subjects was kept to a 
minimum.  
 
Furthermore PTP is a poor indicator of changes in diaphragmatic 
activity at increased lung volume (43). When the lungs are hyperinflated 
the diaphragm is pushed downward and can not generate an adequate 
force. Although there is an increase in energy consuming biochemical 
activity PTP will be low (110). Therefore the respiratory muscle work 
load at higher CPAP levels might have been underestimated.  
 
Oesophageal pressure changes are reflecting pressure changes in the 
pleural space through out the breathing cycle.  It has been shown that 
in lung disease, hyperinflation or rib cage distortion, pleural pressure is 
not equal at all points. Under those circumstances pressure changes in 
the last third of the oesophagus are not representative of pressure 
changes in the total pleural space but only of local pressure changes 
(111;112). This has not been confirmed by Seddon et al. (113) who 
investigated oesophageal pressure lung volumes at different levels of 
PEEP in preterm infants. Therefore measurements of work of breathing 
in the study might not have reflected the true work of breathing. 
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Nevertheless the aim of the study was to investigate improvement or 
deterioration of work of breathing at different nCPAP levels and 
therefore the findings are less affected by these limitations.    
 
It is well known that CPAP increases abdominal distension because of 
swallowed air. This might have altered esophageal and gastric 
pressures especially at higher CPAP levels with higher flow rates and 
measurements of abdominal excursion and thoraco abdominal 
synchrony 
 
The duration of expiratory time might have been influenced by the way 
it was measured. The expiratory phase of abdominal excursion was 
measured from the abdominal signal of the respiratory inductance 
plethysmography, assuming a constant sampling rate of 100 Hz. It is 
likely that EMG activity of the diaphragm occurred before expiration 
could be measured via respiratory inductance plethysmography, which 
would then lead to an underestimation of expiratory time. For the 
purpose of this study, changes in expiratory time at different levels of 
nCPAP are of more interest than the true values.  
 
The quality of each catheter performance was checked regularly.  
Before each use the catheters were calibrated and pressure readings 
Equipment: 
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compared with readings from an industrial hand pump. If the pressure 
readings of the catheter and the hand pump did not correlate the 
catheter was send back to the manufacturer. A possible cause of 
inaccuracies of pressure readings was damaged pressure sensors. The 
pressure sensors might have been damaged due to the acidity of the 
gastric juices or sterilisation solutions. The results of the validation 
studies demonstrated a change of the offset (difference to zero). Such 
changes are not relevant to the study because the data analysis 
included only the calculation of the area under the curve (PTP) and not 
actual pressure values. The correlation coefficient was satisfying 
suggesting accurate measurements of the pressure amplitude and 
therefore the pressure time product. 
 
All subjects were studied in an open heated incubator. It is essential to 
regulate ambient temperature because preterm babies can not maintain 
their temperature. A decrease in body temperature would lead to an 
aggravation of respiratory distress, hypoglycaemia etc.  The elastic 
properties of the Respitrace bands might have been altered during 
measurements, being exposed for 1-2 hours to the heat.    
 
Data analysis: 
A phase shift between the peaks of abdominal and ribcage waves were 
used instead of the shift between each point of the waves. Therefore a 
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number of rib cage waves could not be analysed because of the 
difficulties to identify a single peak. Although the number was reduced 
there was still sufficient data to perform a representative analysis.  
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4.7 Summary  
To my knowledge this is the first study, measuring respiratory muscle 
work load of the ribcage muscles, the diaphragm and abdominal 
muscles at different levels of nCPAP in neonates and to identify non-
invasively determined predictors of the respiratory muscle work load.  
 
It was demonstrated that:  
PTPoe, PTPdi and PTPga, indictors of respiratory muscle work load, 
decreased with increased nCPAP level. 
 
PTPga is greater than PTPoe and PTPdi at all nCPAP levels for 
subjects that are more than 48 hours of age 
 
PTPoe decreased by 7.5%, 8.2% and 8.9% from 2-4 cmH2O, 4-6 
cmH2O and 6-8 cmH2O respectively.  
PTPdi decreased by 8.9%, 9.8% and 10.8% from 2-4 cmH2O, 4-6 
cmH2O and 6-8 cmH2O respectively. 
PTPga decreased by 5.3%, 5.6% and 5.9% from 2-4 cmH2O, 4-6 
cmH2O and 6-8 cmH2O respectively. 
 
“Optimal” nCPAP as determined by the lowest PTPoe and PTPdi 
occurred between 6-8 cmH2O for 56 % of the subjects.  
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“Optimal” nCPAP as defined by the lowest PTPga occurred between 6-
8 cmH2O for 39% of the subjects. 
 
RR, ∆AB and FiO2 decreased, Te increased and HR remained 
unchanged with increased nCPAP level. 
 
PTPoe correlated best out of all three PTP’s with selected variables 
(RR, PA, ∆AB, Te, HR and FiO2). 
 
RR explained 36.7% of the variance of PTPoe 
PA explained 0.7% of the variance of PTPoe 
∆AB explained 45.5% of the variance of PTPoe 
 
The best fitted prediction model for PTPoe and PTPdi consisted of RR, 
PA, ∆AB, BW, GA, nCPAP level and explained 65.8% of the variance 
of PTPoe, 54.8% of the variance of PTPdi.  
The best fitted prediction model for PTPga consisted of ∆AB, nCPAP 
level and explained 41.6% of the variance of PTPga. 
 
 
Summary in lay terms: 
Work of breathing decreased with increased nCPAP levels 
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“Optimal” nCPAP level as defined as the pressure level with the lowest 
work of breathing occurred for 56% of the subjects at higher nCPAP 
levels (6-8cmH2O). 
 
Abdominal excursion was identified as a new valuable parameter to 
measure work of breathing 
 
Parameters commonly used in clinical practice to assess work of 
breathing including respiratory rate or oxygen requirement correlated 
poorly with objective measures of work of breathing. 
 
Best predictors of work of breathing as determined by non-invasive 
methods are a combination of clinical parameters, demographic data 
and objective measures. 
 
 
4.8 Conclusion 
The data suggest that PTP can be predicted more accurately by a 
model consisting of a combination of parameters namely, respiratory 
rate, phase angle, abdominal excursion, gestational age and birth 
weight than by clinical parameters alone. Objective measurements of 
respiratory function are a useful tool but should not be a substitute for 
clinical experience. A combination of the two is desirable and will lead 
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to optimal care of patients. My findings advocate titration of nCPAP 
according to the patient’s respiratory muscle work load.  
 
 
4.9    Future work 
Randomised clinical trials are needed to investigate the benefits of 
nCPAP titration against objective measures of breathing pattern and 
useful clinical endpoints such as reduction in mechanical ventilation and 
improved growth. 
More work is needed to identify what parameter is best to titrate nCPAP 
against. 
Bed side monitoring systems to monitor lung mechanics and respiratory 
parameters for noninvasive respiratory support need to be developed 
and made commercially available 
Alternative methods to calculate respiratory muscle work load should be 
further explored and should be non-invasive and easy to apply in a 
clinical setting. 
Longitudinal studies are needed to identify long term effects of nCPAP 
administration and if these are related to duration of treatment and flow 
rate/pressure level. 
The “Optimal” level of nCPAP still remains to be determined. 
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Appendices 
  
 
 
  Fig. 37a: Frequency distribution of PTPdi at nominal CPAP levels 
  m.PTPdi37 = mean diaphragmatic pressure time product of 37 subjects 
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  Fig.37b: Frequency distribution of PTPga at nCPAP levels 
  m.PTPga37 = mean gastric pressure time product of 37 subjects 
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        Fig. 37c: Frequency distribution of PTPoe at nominal CPAP levels 
          m.PTPoe37 = mean oesophageal pressure time product for 37 subjects 
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Fig.38a: Linear relation ship of PTPoe at nominal CPAP for each                
subject 
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Fig. 38b: Linear relation ship of PTPoe at nominal CPAP for each 
subject 
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Fig. 38c: Linear relation ship of PTPoe at nominal CPAP for each 
subject 
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Table 18: Linear mixed effects model analysis of the effect of the randomisation order on PTPoe 
 value/slope s.e. df t-value p-value 
Intercept  388.8090 24.638570 102 15.780503 0 
 nCPAP    -13.6238 2.403419 102 -5.668494 0 
 
 value/slope s.e. df t-value  p-value 
Intercept 394.7470 25.841318 99 15.275807 0.0000 
nCPAP -13.3595 2.453219 99 -5.445685 0.0000 
randomisation 
order 2 
-7.4697 14.410092 99 -0.518365 0.6054 
randomisation 
order 3 
-5.5359 14.302317 99 -0.387060 0.6995 
randomisation 
order 4 
-15.2331 14.169187 99 -1.075089 0.2849 
DF = degree of freedom
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Fig. 39: The effect of different adjustment periods on PTPoe at different 
nCPAP levels. 
PTPoe = oesophageal pressure time product 
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Fig.40a: Changes of diaphragmatic pressure time product (PTPdi) at 
recCPAP (= nCPAP)  
The data is presented as mean and one standard deviation 
 
 
 
 
 
 
 163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.40b: Changes of gastric pressure time product (PTPga) at recCPAP 
(= nCPAP)  
The data is presented as mean and one standard deviation 
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Fig.40c: Changes of oesophageal pressure time product (PTPoe) at 
recCPAP (= nCPAP) 
The data is presented as mean and one standard deviation 
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Table 19: Relationship between PTPoe and the clinical characteristics of the sample population 
parameter estimate Standard error t-value Pr ( >| t | ) Multiple R squared 
GA weeks -0.2207 0.5010 -0.440 0.663 0.00642 
CA hours -0.01056 0.44818 -0.024 0.981 1.852e-0.5 
Birth weight g 0.5782 0.5348 1.081 0.288176 0.03751 
Gender male 1.1941 0.6871 1.738 0.0925 0.09147 
Ethnic origin mixed race 1.0778 0.6816 1.581 0.124 0.07693 
Antenatal steroids 0.4773 0.7403 0.645 0.524 0.01367 
surfactant 0.5492 0.7244 0.758 0.454 0.0188 
HIV+ -1.0737 0.9552 -1.124 0.27 0.04042 
VDRL+ 1.345 1.042 1.290 0.20675 0.05259 
PDA mild 0.745 1.883 0.396 0.69522 0.00537 
PDA severe -0.6457 0.8357 -0.773 0.446 0.02017 
GA=gestational age, CA=chronological age, HIV+ = positive for Human Immunodeficiency Virus, VDRL+ = Venereal Disease Research Laboratory 
test positive, PDA = persistent ductus arteriosus, PTPoe = oesophageal pressure time product
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Technical specifications: 
 
Characteristics of Pressure transducer (Gaeltec Ltd) 
Sensor : Metal diaphragm with directly deposited resistive strain gauges 
Excitation : 5V AC r.m.s. maximum or 1V DC maximum 
Bridge resistance : 1.5kW nominal 
Sensitivity : 5mV/V/mmHg 
Linear pressure range : 0 - 150mmHg 
Compensated temperature range : 15 - 40°C 
Temperature coefficient of zero : < 0.05%FS/C° 
Zero drift : < 1mmHg in 24 hours 
Temperature coefficient of sensitivity : < 0.2%/C° 
Linearity and hysteresis error : < ±1%FS BSL 
Overpressure : 1200mmHg 
In free air or water, the resonant frequency of the sensor is in the region 
of 12 KHz,  
RIP unit (Respitrace VIASYS Healthcare GmbH, Netherlands):  
The system capacity is 12 bit = 4.906 bins with analogue output. 
The analogue input from the oesophageal gastric pressure sensors will 
be converted (AD converter 0-5 V) into a digital output. 
 
CO2SMO® Plus Monitor, Model 8100, (Respironics, Inc. France) 
Pulse Oxymetry 
The CO2SMO® Plus determines oxygen saturation using sensors that 
contain red and infrared (660 and 940 manometer) light sources, called 
light emitting diodes (LEDs). The light energy from each LED is beamed 
through a tissue sample—a pulsating vascular bed such as the patient’s 
finger or toe. The remaining light energy not absorbed by the tissue 
sample reaches a photodiode light receptor in the sensor. Oxygen 
saturated blood absorbs different amounts of light at each wavelength 
as compared to desaturated blood. Therefore, the amount of light 
absorbed by the blood in each pulse can be used to 
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calculate oxygen saturation. The CO2SMO® Plus is calibrated to 
display “functional” saturation. The amount of oxyhaemoglobin as a 
percentage of the haemoglobin that can be oxygenated. Dysfunctional 
haemoglobins (COHb and METHb) are not included in the 
measurement of functional saturation.  
 
Oxygen Saturation 
Range: 0-100% 
Accuracy: ±2% for 80 -100% (1 standard deviation or approximately 
68% of readings are within the accuracy claim), unspecified for 0-79% 
Display Resolution: 1% 
Averaging Time: Menu selectable 2 or 8 seconds 
Pulse Rate is calculated by measuring the time interval between peaks 
of the infrared light waveform. The inverse of this measurement is 
displayed as pulse rate. The oxygen saturation and pulse rate values 
are updated once each second.  
• Pulse Rate 
Range: 30-250 beats per minute 
Accuracy: ±1% of full scale 
Display Resolution: 1 beat per minute 
Averaging Time: fixed at 8 seconds 
 
Flow Sensor Specifications 
• Flow Range (L/min):   
Neonatal Flow - 0.25 to 25 
Neonatal CO2/Flow - 0.25 to 25 
• Flow Accuracy: 
Neonatal Flow - Greater of ±  3% reading or .125 L/min 
Neonatal CO2/Flow - Greater of ± 3% reading or .125 L/min 
• Minute Volume Range (L/min):   
Neonatal Flow 0.1 to 15 
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Neonatal CO2/Flow 0.1 to 15 
• Tidal Volume Range (ml):    
Neonatal Flow - 1 to 100 
Neonatal CO2/Flow - 1 to 100 
• Airway Pressure Range (cm H2O): s 
Neonatal Flow -120 to 120 
Neonatal CO2/Flow -120 to 120 
• Added Dead Space (ml): Neonatal Flow - less than 1 ml 
Neonatal CO2/Flow - less than 1 ml 
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 Fig. 41: Main running screen illustrating different signal pathways derived by RIP and CO2SMO plus 
